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Fluorescent probes have emerged as a class of promising imaging reagents in cancer 
cell detection as well as broad biological imaging applications. During past decades, 
organic dye and quantum dots (QDs) have been highly relied on for fluorescence 
imaging studies. Recently, a novel class of fluorescent nanoparticles, conjugated 
polymer based fluorescent nanoparticles (CP NPs), have been reported to show high 
brightness, good photostability and low cytotoxicity in cellular imaging studies, which 
make them promising alternatives to conventional fluorescent probes. However, 
surface functionalized CP NPs with good targeting ability to specific cancer cells and 
intracellular biomolecules remain lack for CP NP based bioimaging assays. In this 
thesis, various CP NPs with desired fluorescence properties, surface functionalities, 
and low cytotoxicity have been developed for targeted cancer cell imaging and 
intracellular target detection. 
Firstly, a general and feasible strategy to fabricate biocompatible and 
surface-amendable conjugated polymer based fluorescent nanoparticles has been 
developed and their application in targeted cancer cell imaging has been demonstrated. 
Following that, polyhedral oligomeric silsesquioxanes (POSS) based conjugated 
polymer has been used to improve the quantum yield of CP NPs. Further conjugation 
of these nanoparticles with antibody allowed for detection of targeted cells with good 
selectivity. Subsequent efforts were made to simultaneously discriminate different 
cancer cells in mixed cell suspension under single laser wavelength excitation. At last, 
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intracellular biotarget detection in living cells were carried out using water-soluble 
hyperbranched conjugated polymer nanospheres with small size, good living cell 
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Cancer is one of the most serious disease which has become the leading cause of death 
today.1 Detection of cancer at its early stage remains a vital challenge and is of high 
importance in prognosis and treatment of cancer patients.2-3 Various modalities 
including magnetic resonance imaging, computer tomography, positron emission 
tomography and fluorescence imaging techniques have made significant contribution 
in cancer diagnosis.4 Among these advanced techniques, fluorescence techniques have 
emerged as an important platform for cancer cell imaging and other bioimaging 
applications in cancer diagnosis, due to their advantages in terms of relatively 
inexpensive and more maneuverable equipments.5 As the performance of fluorescence 
imaging is highly relied on the properties of fluorescence probes, development of 
advanced imaging reagents to satisfy more specific bioimaging studies remains urgent 
demand in practice.  
Nanoparticles with unique optical, functional and structural properties that are not 
available from discrete molecules and bulk materials make them attractive in cancer 
cell imaging and cancer diagnosis and treatment.6-7 Two main groups of fluorescent 
nanoparticles, organic dye doped silica or polymeric nanoparticles and quantum dots 
(QDs), have been intensively used for cellular imaging8 and in vitro as well as in vivo 
studies.9 Despite the successful application of these conventional fluorescent probes, 
their intrinsic problems such as small Stocks shift of organic dye doped nanoparticles 
and toxicity of QDs make the exploration of new generation of fluorescent 
nanoparticles remain high concern to overcome these disadvantages. Recently, 
conjugated polymers have been reported to show high fluorescence and low 
cytotoxicity,10 which have become a novel class of alternatives to these conventional 
                                                                       Chapter 1 
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fluorescent probes for bioimaging. Various strategies have been developed to fabricate 
conjugated polymer based fluorescent nanoparticles to explore their applications in 
fluorescence imaging studies.  
In this chapter, we start with the review of the design and applications of different 
types of fluorescent nanoparticles in in vitro and in vivo imaging, which is followed by 
the introduction of conjugated polymers. Then, the applications of conjugated 
polymers in biological studies are briefly discussed and the optical properties and 
performance of various conjugated polymer based fluorescent nanoparticles in the 
literature are reviewed in details. At last, the objectives of this Ph.D. project are 
introduced, followed by the organization of this thesis. 
1.2 Research Objectives 
As a promising generation of fluorescent probes, CP NPs have attracted great interest 
in bioimaging applications with great advantages over conventional ones in terms of 
large Stokes shift, good photostability and low cytotoxicity, which will greatly benefit 
their applications in bioimaging.10 As compared to sophisticated synthesis of water 
soluble conjugated polymers through introducing water-soluble side chains, 
preparation of CP NPs is a more feasible and general strategy. Considering the fact that 
the optical properties of conjugated polymers can be precisely customized by chemical 
structural modifications, these CP NPs have great potential to meet specific 
requirements in various bioimaging applications. In addition, the development of 
versatile surface functionalities of CP NPs allows efficient conjugation with 
biomolecules or targeting ligands to facilitate targeted imaging. However, in most of 
the initial studies, CP NPs have been used as non-specific cell staining reagents and 
targeted cell imaging by surface functionalized CP NPs still remains unexplored.  
                                                                       Chapter 1 
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In this contribution, this thesis focuses on the fabrication and optimization of surface 
functionalized CP NPs for targeted cancer cell imaging through fine-tuning the 
polymer structure and engineering surface property with targeting ligands. After 
successful demonstration of functionalized CP NPs in single target cell detection, their 
performance in multiple cancer cell detection in one mixture will be further 
investigated. Besides targeted cancer cell imaging, initial efforts have been made to use 
conjugated polymer based fluorescent nanoprobes for intracellular biomolecule 
detection in living cells. 
The specific objectives are summarized as follows. 
1. To develop a general and feasible strategy to synthesize surface-amendable and 
biocompatible CP NPs in one step using an encapsulation matrix with terminal 
functional groups.  
2. To demonstrate the application of surface functionalized CP NPs in targeted cancer 
cell detection after conjugation with specific targeting moieties such as folic acid, 
antibody and peptide.  
3. To improve the quantum yield of CP NPs through mordification of CP molecule 
backbone structures to achieve higher contrast imaging for more sensitive assays. 
4. To synthesize CP NPs with desired fluorescence properties and surface targeting 
moieties for simultaneous detection of different cancer cells in one mixture under 
single excitation wavelength.  
5. To extend the application of conjugated polymer based nanoprobes in intracellular 
target imaging in living cells.  
Through this Ph.D. project, we anticipate exploring a novel class of conjugated 
                                                                       Chapter 1 
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polymer based fluorescent probes with specific targeting ability and illuminating new 
opportunities in further development of CP NPs in in vitro and in vivo bioimaging. 
1.3 Thesis Outline 
This thesis consists of seven chapters. Chapter 1 introduces the research background 
and objectives of this Ph.D. project. Chapter 2 reviews the progress of fluorescent 
nanoparticles in literature. In Chapter 3, a simple strategy to fabricate a series of CP 
NPs with surface carboxyl groups is developed using biocompatible 
poly(DL-lactide-co-glycolide) (PLGA-COOH) as an encapsulation matrix. The 
as-prepared CP NPs are subsequently functionalized using folic acid and their targeting 
ability to folate receptor-overexpressed cancer cells is evaluated, which provides 
guidelines for CP NP design and functionalization in the following chapters. In 
Chapter 4, CP NPs are conjugated with a more specific targeting moiety, antibody 
(trastuzumab), to achieve selective discrimination of breast cancer cells with 
overexpression of HER2 from the ones that have low HER2 expression. In addition, 
the quantum yield of CP NPs is improved by introducing a rigid core into polymer 
chains, which benefits their performance in cell imaging. Based on the study on single 
type of target cell detection, Chapter 5 presents a strategy to fabricate two surface 
functionalized CP NPs with similar absorption maxima and different emission 
wavelengths for simultaneous discrimination of targeted cancer cells in one mixture 
under single wavelength excitation. In Chapter 6, the first demonstration of conjugated 
polymer based fluorescent probe (hyperbranched conjugated polyelectrolyte 
nanosphere) for intracellular biomolecule imaging in living Hela cells is illustrated. 
The novel intracellular fluorescent probe shows great advantages in living cell 
internalization and photostability as compared to commercially available organic dye 
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conjugates. Chapter 7 gives the conclusion and recommendation of this project. 
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2.1 Conventional Fluorescent Materials 
2.1.1 Organic Dye Doped Nanoparticles for Bioimaging 
Organic fluorescent dyes are the most commonly used fluorophores in various 
biological applications. Traditional organic dyes (eg., FITC, rhodamine B 
isothiocyanate and Cy5) and their antibody/ligand conjugates have been actively used 
in various biological studies, including cell imaging and targeted organelle detection.1 
However, directly using organic dyes is not able to keep pace with the booming 
development of bioimaging studies due to their intrinsic disadvantages: 
(1) Traditional organic dyes suffer from poor photostability, which leads to rapid 
photobleaching under continuous excitation for extended periods.2 Hence, they are not 
suitable for long-term bioimaging assays. 
(2) Their optical properties (eg., excitation and emission) are often susceptible to 
changes in local chemical environment (e.g., pH and interacting ions), which can 
mislead the analysis of experimental results.3 
The two main problems of organic dyes listed above are mainly caused by direct 
interaction between dyes and cellular environment. As a consequence, encapsulation of 
organic dyes into matrix to synthesize dye doped fluorescent nanoparticles is an 
efficient strategy to improve their stability for both in vitro and in vivo imaging 
applications. Moreover, dye doped nanoparticles always possess higher fluorescence 
intensity as compared to discrete dye molecules due to the large number of dye 
molecules encapsulated in each particle. The commonly used encapsulation matrices 
include lipid,4 polymer5 and silica.6 Direct interaction between oxygen, other 
chemicals and dye molecules is minimized after encapsulation, which can result in 
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improved photostability and chemical stability.7 Moreover, the surface functional 
groups on nanoparticles allow universal bioconjugation reactions to immobilize 
biomolecules or targeting ligands for targeting purpose.8 Among different types of dye 
doped nanoparticles, dye doped silica nanoparticles have shown advantages over 
others as follows:9 Firstly, silica nanoparticles have better stability and low dye 
molecule leakage in aqueous solutions than polymeric nanoparticles. Secondly, the 
preparation of silica nanoparticles is easy and well-established and their surface can be 
easily customized to facilitate further modification by various targeting ligands to 
achieve specific targeted biodetection. 
Typically, dye doped silica nanoparticles are prepared either by 
microemulsion-mediated method10 or Stöber’s method.11 Nanoparticles with relatively 
uniform size can be prepared from microemulsion-mediated method but the yields are 
always very low.12 On the other hand, using Stöber’s method can easily obtain large 
amounts of nanoparticles and avoid the use of potentially toxic organic solvents and 
surfactants.13 In a typical Stöber’s method, alkoxysilane compounds, including 
tetraethylorthosilicate (TEOS), tetramethylorthosilicate (TMOS) and their derivatives, 
undergo base-catalyzed hydrolysis and condensation reaction in mixture containing 
ammonia, ethanol and water. During the process, organic dye molecules can be 
encapsulated into silica matrix to yield fluorescent nanoparticles and the precursors 
used during preparation renders nanoparticles with surface functional groups.  
In 2004, He et al. reported the synthesis of FITC doped silica nanoparticles with amino 
groups on the surface.14 The obtained fluorescent nanoparticles were covalently 
immobilized with anti-human monoclonal antibody HAb18 to achieve HepG liver 
cancer cell detection with good selectivity. The surface of silica nanoparticles can be 
customized to have desired functional groups by using various precursors during 
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nanoparticle synthesis, which can facilitate their conjugation with various 
biomolecules containing different reaction groups. Prasad et al. developed a strategy to 
synthesize rhodamine-B doped silica nanoparticles with different surface active groups, 
including hydroxyl, amine, carboxyl and thiol groups.15 After conjugation with 
transferrin and monoclonal antibody, the targeted cancer cell uptake of these 
functionalized nanoparticles was much higher than that of the nonconjugated ones due 
to the targeting ability rendered by surface biomolecules. 
Besides single target detection, simultaneous multiplex detection is always desired. In 
these high sensitive assays, multi-laser sources are always necessary to efficiently 
excite each corresponding type of fluorophore in fluorescent nanoparticles as they 
have distinct absorbance properties. Recently, multicolor silica nanospheres which 
encapsulate different organic dye molecules for simultaneous multiplex cell mixture 
detection under single laser excitation have also been reported.16 However, the intrinsic 
small Stokes shift of dye molecules and the emission spectrum overlap among 
different dyes can lead to signal interference among dye doped nanoparticles when 
excited at a single wavelength. Moreover, for multiple dye doped silica nanoparticles, 
the doping ratio among different dyes needs to be precisely controlled in order to 
achieve desired fluorescent properties and to avoid batch-to-batch variations, which 
further increases complexity and reduces reproducibility of the assays. As a 
consequence, organic dye doped fluorescent nanoparticles are not well suited for 
multiplex imaging applications. 
2.1.2 Quantum Dots for Bioimaging 
QDs are a class of spherical semiconductor crystals with diameters in the range of 2-10 
nm, containing roughly 200-10,000 atoms. Generally, they are composed of elements 
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from group II-VI, III-IV or IV-VI from the periodic table. These nanoparticles have 
attracted great interest in optoelectronic device fabrication and biological detection, 
due to their unique semiconducting nature and the size-dependent fluorescence.17 
Taking advantage of their unique structural properties, QDs are brighter and more 
stable against photobleaching as compared to organic dyes. Moreover, they have broad 
absorption and narrow emission, which ensure efficient excitation with a single light 
source and small fluorescence overlap among different probes. These merits have 
motivated scientists to apply QDs in wide applications in bioimaging. 
Since the first report on QD design and synthesis in 1982,18,19 a wide variety of 
synthetic methods have been developed to prepare QDs in different media, including 
aqueous solution,20 high-temperature organic solvents21 and solid substrates.22 Initially, 
colloidal suspensions of QDs are usually synthesized by introducing semiconductor 
precursors under conditions thermodynamically favoring crystal growth. The presence 
of semiconductor-binding agents is able to kinetically control crystal growth. 
Considering the size-dependent optical properties of QDs, it is essential to synthesize 
QDs with narrow size distributions to ensure the desired fluorescence properties. 
Bawendi et al. made an important contribution to synthesize monodispersed QDs using 
different precursors.23 Up to now, the synthesis of CdSe QDs has achieved great 
accomplishment to obtain QDs with emission wavelengths covering the range of 
visible spectrum. In the typical CdSe QD synthesis, the finally obtained QDs are 
usually hydrophobic due to the coordinating ligands coating on surface. To satisfy 
various biological applications, different techniques have been applied to modify CdSe 
QDs such as coating them with an inorganic shell to reduce cytotoxicity24 and 
modifying surface to render them good colloidal stability and ability for further 
biomolecule conjugation.25 The classic synthetic process of core-shell QDs is to 
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prepare CdSe cores in a nonpolar solvent and to use a zinc sulfide (ZnS) shell to grow 
on the surface. 
The aliphatic coordinating ligands on pristine QD surface greatly restrict their direct 
applications in biological studies because they are only soluble in organic solvents. 
Although direct synthesis of QDs in aqueous solution has been reported, these QDs 
have poor monodispersity, stability and fluorescent efficiency as compared to those 
synthesized in high temperature coordinating solvents.26 Two general strategies, ligand 
exchange and encapsulation by an amphiphilic polymer, have been developed to render 
QDs good solubility in aqueous solution. As ligand exchange is always associated with 
compromised fluorescence efficiency,27 covering the hydrophobic QDs with an 
amphiphilic polymer becomes a more commonly used strategy to yield water soluble 
QDs.28 The hydrophobic segments can coat QD surface through hydrophobic 
interactions while the hydrophilic segments orient into water phase. The obtained QDs 
are able to be dispersed in aqueous solution and remain stable for a long time. 
Moreover, the polymer-encapsulated water-soluble QDs have desirable surface 
functionalities for further conjugation with targeting moieties. 
By choosing different amphiphilic polymers with desired functional groups coated on 
QD surface, water-soluble QDs can be conjugated to various targeting ligands, such as 
antibodies29 and peptides.30 In addition, the surface of QDs can also be modified with 
polyethylene glycol (PEG) to eliminate possible nonspecific binding and decrease the 
rate of clearance from the bloodstream in in vivo imaging studies. According to 
literature, QDs functionalized with targeting ligands will yield high specificity for a 
variety of cellular membrane receptors and targets.31,32 After conjugation with nuclear 
localization signal peptide, QDs can be efficiently internalized into cell nuclei and the 
movement of peptide conjugated QDs from cytoplasm to nuclei can be monitored.33 
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Dahan et al. reported that QDs could be functionalized by an antibody fragment 
specific for glycine receptors on the membranes of living neurons to realize single 
receptor tracking.34 The reported QD conjugates had higher photostability and 
sensitivity as compared to organic dyes, indicating their superiority in bioimaging 
applications. Lidke et al. used epidermal growth factor to modify CdSe/ZnS QDs for 
specific detection of epidermal growth factor receptor in cell membranes.35 Upon 
incubation of these QD conjugates with the target human cancer cells, the bright and 
stable fluorescence emitted from these QDs allowed long term observation of protein 
diffusion on the cell membrane. Besides the cell membrane receptor detection, study 
and visualization of receptor dynamics with QD conjugates have also been explored.36 
Gao et al. reported the development of antibody and PEG modified QD probes 
encapsulated in triblock copolymers that were suitable for targeting and imaging of 
human prostate cancer cells in vivo.37 In this strategy, a ZnS shell grew on the CdSe 
core to improve chemical stability of the obtained QDs. A single CdSe/ZnS QD was 
then encapsulated in a triblock polymer via a spontaneous self-assembly process. The 
polymer-coated QDs were then conjugated by affinity ligands to prostate-specific 
membrane antigen (PSMA) overexpressed in human prostate cancer cells. As shown in 
Figure 2.1, the as-prepared bioconjugated QDs were found to be efficient for active 
tumor targeting due to rapid antibody binding to tumor-specific antigens and the 
surface PEG segments with good antibiofouling ability which could help prolong the 
QD circulation time in vivo.  




Figure 2.1 In vivo fluorescence images of tumor-bearing mice using QD probes with 
carboxylic acid groups (left), PEG groups (middle) and PEG-PSMA antibody 
conjugates (right). Copyright Nature Publishing Group 2004. 
 
Although significant progresses have been made in imaging membrane proteins on 
living cells by QD conjugates, only limited progress has been made in using QDs for 
living cell imaging in cytoplasm, mainly due to the lack of efficient methods for 
delivering monodispersed QDs into cytoplasm of living cells. Many studies show that 
QDs are prone to aggregate inside cell cytoplasm, and are often trapped in endosomes 
and lysosomes. To deliver QDs into living cells, various techniques have been 
proposed, including passive uptake, cationic lipid transfection, microinjection and 
electroporation. It has been found that the efficiency of extracellular substrates uptake 
by cells can be dramatically enhanced by coupling QDs to cell membrane receptors, 
which is most likely caused by the avidity-induced increase in local concentration of 
QDs at the cell surface, as well as an active enhancement caused by receptor-induced 
internalization.38,39 However, these methods may result in QD aggregation in vesicles. 
Previous studies have shown that using cationic lipids or peptides can achieve 
enhanced plasma membrane translocation for intracellular delivery of 
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biomolecules.40,41 Ruan et al. synthesized Tat peptide-conjugated QDs that acted as a 
model system to examine the cellular uptake and intracellular transport of 
nanoparticles in living cells.42 The study suggested that the Tat peptide-conjugated 
QDs could be efficiently internalized through macropinocytosis. Besides QD surface 
chemical modification to render them living cell membrane permeability, mechanical 
delivery methods including microinjection and electroporation are also generally 
employed. Microinjection was reported to be able to deliver QDs homogeneously into 
the cell cytoplasms.43 However, microinjection is of low statistical values because 
careful manipulation of single cell greatly restricts the application in large sample sizes. 
On the other hand, electroporation, which increases cell membrane permeability under 
pulsed electric fields to deliver QDs into living cells, may cause serious aggregation of 
the probes in the cytoplasm and lead to obvious cell death. Moreover, these methods 
always have disadvantages in limited transfer efficiency, complicated operation 
procedures and potential ability to disrupt cell membranes. 
The applications of QDs for intracellular target detection have also been reported. Wu 
et al. reported the specific labeling of cancer marker Human Epidermal growth factor 
Receptor 2 (Her2) and intracellular target in fixed and permeabilized target cells.44 The 
QDs used in this study were functionalized by immunoglobulin G (IgG) and 
streptavidin to specifically stain the breast cancer marker (Her2) on the surface of fixed 
and living SKBR-3 cells, actin and microtubule fibers in the cytoplasm of mice 
fibroblast cells as well as the nuclear antigens inside the nucleus after fixation and 
permeabilization. The QDs showed specificity to targets and brighter fluorescence with 
better photostability than comparable organic Alexa dyes. Simultaneous detection of 
two targets in cells with one excitation laser was also achieved using different QD 
conjugates with different emission spectra. On the contrary to the efficient and specific 
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detection of intracellular targets in fixed and permeabilized cells, labeling biotargets in 
living cells using QDs still remains a great challenge in practice. In order to avoid 
potential damage in living cell imaging caused by microinjection and electroporation, 
different strategies using nanocarriers have been proposed. Yoo et al. synthesized QDs 
conjugated with various targeting ligands and prepared the QD/transfection reagent 
complex to enhance living cell internalization of the QD conjugates to label 
intracellular targets.45 Chan et al. reported the fabrication of antibody-conjugated QDs 
encapsulated in biodegradable polymeric nanoparticles for filamentous actin detection 
in living Hela cells.46 After entering living cells, the polymeric matrix gradually 
decomposed to release the QD bioconjugates to stain actin in cytoplasm. However, 
these studies show poor performance as the specificity of these QDs conjugates to 
intracellular targets is very low in living cells. Novel fluorescent probes with good 
selectivity and living cell membrane permeability are highly desirable. 
2.2 Conjugated Polymers 
Conjugated polymers are unsaturated rigid-rod macromolecules with sp1- or 
sp2-hybridized backbones composed of unsaturated double or triple bonds of carbon or 
aromatic rings linked by single bonds.47 Due to the highly delocalized π-electrons 
along the polymer backbone, conjugated polymers have distinguished fluorescence 
properties and conductive properties, which motivate the scientists to explore their 
applications in various research fields. The optical and conductive properties of 
conjugated polymers can be desirably fine-tuned through using different conjugated 
backbones and side chains. The backbone structures of commonly used conjugated 
polymers are shown in Figure 2.2, including poly(fluorene)s (PFs), poly(p-phenylene)s 
(PPPs), poly(phenyleneethynylene)s (PPEs), poly(p-phenylenevinylene)s (PPVs) and 
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poly(thiophene)s (PTs). Up to now, this class of macromolecules has emerged as one 
of the most active materials in design of electronic devices,48 biomaterials49 and 
biosensors/chemical sensors.50  
 
Figure 2.2 Chemical structures of conjugated polymers. 
 
The fluorescence of conjugated polymers can be illustrated with the classic Jablonski 
diagram. As shown in the Jablonski diagram in Figure 2.3, conjugated polymer in an 
excited state will lose the absorbed energy in different ways: nonradiative (internal 
conversion and intersystem crossing) and radiative (fluorescence and phosphorescence) 
pathways. After absorption of energy, conjugated polymers are excited from the lowest 
energy level of electronic state (S0) to excited singlet electronic state (S2). Vibrational 
relaxation leads to the lowest energy level of the corresponding excited singlet state 
while internal conversion leads to lower excited singlet electronic state (S1). Emission 
of radiation from the lowest energy level of excited singlet state (S1) to the ground 
state (S0) is defined as fluorescence. Intersystem conversion leads to triplet state (T1) 
and the emission of radiation from T1 to S0 is defined as phosphorescence. The lifetime 
of fluorescence (pico- to nano- second) is much shorter as compared to that of 
phosphorescence (micro- to mili- second). Lots of studies of conjugated polymers have 
been focused on their fluorescence properties. 
R R












Figure 2.3 Jablonski diagram. A: vibrational relaxation, B: internal conversion, C: 
intersystem crossing. S0: ground singlet state, S1: first excited singlet state 1, S2: 
second excited singlet state 2, T1: excited triplet state 1. 
 
The absorption and emission signatures of conjugated polymers are highly associated 
with their polymer structures and conformations in solution or solid state. The main 
critical factors to determine their fluorescence properties include effective conjugation 
length of backbones, polymer chemical structures as well as the molecular 
conformation and packing.51 First of all, the emission wavelength highly relies on the 
conjugation length of conjugated polymers. Increasing the conjugation length in 
general leads to longer emission wavelength. It should be noted that the fluorescence 
of conjugated polymers will not change further if the length of polymer chain exceeds 
beyond the effective conjugation length. Meanwhile, the emission wavelength can be 
fine-tuned by changing the charge density of conjugated polymers, which is always 
achieved through changing the side chains attached on the polymer backbones or 
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2.2.1 Conjugated Polymers for Biosensors 
Water-solubility of conjugated polymers is essential for their applications in biological 
studies. Generally, ionic or hydrophilic side chains are attached to conjugated polymers 
to yield water-soluble conjugated polyelectrolytes, which combine the optoelectronic 
properties of conjugated polymers and the construction of chemical and biological 
sensors.52 The chemical structure of conjugated polyelectrolytes allows for effective 
electronic coupling and therefore facilitates intra- and interchain energy transfer.53 
Conjugated polyelectrolyte based sensors are sensitive to minor perturbations, due to 
amplification by the collective response, which offers advantages when compared with 
small molecule counterparts.54 This collective response influences optoelectronic 
properties, such as absorbance, Förster resonance energy transfer (FRET), electrical 
conductivity, and fluorescence efficiency, which can be used to report, or “transduce”, 
target analyte presence. Various groups have made great efforts on the conjugated 
polyelectrolyte based biosensors for biomolecule detection.55-58 
Swager et al. demonstrated amplified fluorescence quenching of conjugated polymers 
in 1995.59 The greatly enhanced sensitivity of conjugated polymers relative to small 
molecule counterparts in the presence of quenchers is believed to be derived from the 
delocalized electron structure of conjugated polymers, which facilitates efficient 
energy migration along the polymer backbone. As shown in Figure 2.4, a single bound 
quencher molecule is able to trap almost all the excitons along the polymer backbone. 
Qualification of conjugated polymer fluorescence quenching is determined by 
Stern-Volmer equation: 
F0/F = 1 + KSV[Q] 
where F0 is the fluorescence intensity in the absence of quencher, F is the fluorescence 
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intensity in the presence of quencher [Q], and KSV is the Stern-Volmer constant.  
 
Figure 2.4 Schematic illustration of the mechanism of amplified quenching of CP 
upon interaction with an electron transfer quencher. Copyright American Chemical 
Society 1995. 
 
The amplified quenching effect allows design conjugated polymer-based protein and 
DNA sensors by monitoring the fluorescence change of conjugated polymers in the 
absence and presence of analytes. “Quencher-tether-ligand” (QTL) approach was one 
of the earliest protein assays that operate on conjugated polymer fluorescence 
quenching and dequenching.60 The approach involved the use of a biotin linked 
cationic quencher (methyl viologen MV2+). The fluorescence of anionic PPV in 
aqueous solution was efficiently quenched by a very small amount of biotin linked 
MV2+ (B-MV). Addition of avidin was able to significantly recover the polymer 
fluorescence due to specific interactions between biotin and avidin that could pull 
B-MV off from the vicinity of PPV. In addition to the reported specific interactions, 
studies from Heeger and Bazan et al. revealed that nonspecific interactions between 
protein and conjugated polymers existed in these assays, which could significantly 
affect the operation and selectivity.61 To minimize the electrostatic interaction between 
proteins and conjugated polymers, a concept of charge neutral complex (CNC) was 
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Quenching of CNC fluorescence by a negatively charged dinitrophenol (DNP) 
derivative and specific dequenching upon addition of anti-DNP antibody were 
demonstrated. In addition, the quenched fluorescence of CNC could not be recovered 
when nonspecific antibody rat IgG or a nonspecific quencher (2,4,6-trinitrophenol, 
TNP) to anti-DNP antibody, indicating the specificity of this protein sensor.  
Later, a reliable method based on long-range FRET from a conjugated polymer to a 
corresponding signaling chromophore has been commonly used for DNA detection, 
where the polymer serves as the energy donor and the signaling chromophore serves as 
the energy acceptor.62 The high extinction coefficients and highly delocalized 
backbone made conjugated polymers excellent energy donors in FRET based assays to 
amplify the acceptor signal, yielding high sensitivity and selectivity with minimized 
background signals. The assay generally contained two ingredients: a light harvesting 
cationic conjugated polyelectrolyte and a probe oligonucleotide attached to a 
luminescent signaling chromophore (C*). The absorption bands of conjugated 
polyelectrolyte and C* were chosen to have minimal overlap and the emission spectra 
of the two species occur at clearly differentiated wavelengths. The solution contained a 
conjugated polyelectrolyte and a peptide nucleic acid (PNA) strand labeled with C*. 
Upon addition of single strand DNA (ssDNA), two different situations were 
encountered. When the ssDNA added in the solution was complementary to the PNA 
probe, hybridization of the neutral PNA-C* probe and the negatively charged ssDNA 
target produced a duplex with a net negative charge and resulted in favorable 
electrostatic interactions between the duplex and the cationic conjugated 
polyelectrolyte. On the contrary, when a single stranded DNA that could not match the 
PNA sequence was added, hybridization did not take place and no FRET occurred. As 
a result, the existence of target strand which was complementary to the PNA probe can 
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be determined by monitoring the fluorescence of fluorescein upon polymer excitation.  
Unlike the need of attachment of quencher or reporter, label-free detection of DNA 
and bovine serum albumin (BSA) using conjugated polyelectrolytes were also 
achieved by our group.63 The operation mechanism was based on aggregation-induced 
FRET from the fluorene segments to 2,1,3-benzothiadiazole (BT) units.64 In this study, 
we developed cationic CPs containing BT units as fluorescence ‘light-up’ probes for 
DNA and BSA sensing based on the understanding that BT emission is sensitive to 
environmental polarity due to its charge transfer electronic states. The polymers have 
shown very weak fluorescence in aqueous media. Addition of DNA or BSA to the 
polymer solution significantly enhanced polymer fluorescence due to the increased 
hydrophobicity of polymers upon complex formation with biomacromolecules. 
Moreover, the polymers exhibited linear fluorescence enhancement as a function of 
BSA concentration. 
Many diseases are associated with misfolded proteins, making the detection of the 
structure of protein aggregates and the conformational changes in proteins remain 
urgent concern. Nilsson et al. developed a strategy to use PTs for detection of protein 
aggregates.65 The flexible backbones and rotational freedom of PTs were restricted 
upon binding to protein aggregates to yield fluorescence change with specific 
spectroscopic signature. The authors further reported a real-time visualization of 
cerebral protein aggregates in transgenic mouse models of neurodegenerative diseases 
using oligothiophene derivates.66 Ex vivo spectral assignment of distinct prion deposits 
from two mouse-adapted prion strains was realized using one of the oligothiophene 
derivates and neurofibrillary tangles were readily distinguished by their strong 
fluorescence. The study indicated that oligothiphenes derivates could be used as 
powerful tools for investigating protein aggregation diseases and amyloid origin.  
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2.2.2 Conjugated Polymers for Cell Imaging 
Recently, conjugated polyelectrolytes have been explored for cell imaging studies. 
Initial effort has been made by Bunz et al., who demonstrated the application of 
folate-functionalized anionic PPE as the fluorescent probe to image cancer cells. In 
this study, folic acid, used as the targeting ligand, was attached to an 
amine-functionalized PPE via an amide coupling agent. The folate-PPE showed 
targeting ability to allow clear in vitro imaging of KB cancer cells with good selectivity. 
On the other hand, NIH/3T3 fibroblast cells did not show obvious fluorescent labeling 
due to the low folate receptor expression. The folate-PPE entered into KB cells 
through folate receptor-mediated endocytosis, which was evidenced by laser scanning 
confocal microscopy and fluorescence microscopy. The PPEs showed good 
photostability and minimal cytotoxicity, which made the conjugated polymer based 
probes superior to organic fluorescent dyes and cytotoxic QDs. In 2008, the same 
group reported that carboxylated anionic PPE could serve as a specific targeting probe 
for selective recognition of the extracellular matrix protein fibronectin in living 
fibroblast cells through polyvalent interactions.67 The specific recognition of 
fibronectin was confirmed by colocalization of commercially available anti-fibronectin 
in living cells. 
Our group has been working on the synthesis of various conjugated polyelectrolytes to 
meet specific requirements in cell imaging studies. In 2009, Liu et al. reported the 
synthesis of water-soluble fluorescent hyperbranched conjugated polyelectrolyte 
(HCPE) with core-shell nanospherical structure via the combination of alkyne 
polycyclotrimerization and alkyne-azide ‘click’ reaction.68 The obtained HCPE 
nanospheres have shown high quantum yield in aqueous solution, good solution 
stability and low cytotoxicity. After incubation with MCF-7 cancer cells, bright 
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fluorescence signal could be detected from cytoplasm, indicating the HCPE 
nanospheres were efficiently internalized into living cells. The same group also 
synthesized cationic conjugated oligoelectrolyte substituted polyhedral oligomeric 
silsesquioxanes (COE-POSS) with QD size for cell nucleus imaging through FRET to 
commercially available ethidium bromide or two photon fluorescence imaging 
techniques.69,70  
In addition to these demonstrations of conjugated polyelectrolytes for nonspecific cell 
staining, our group also reported the design of self-assembled fluorescent probe with 
far red/near infrared (FR/NIR) emission and folic acid functionalization to realize 
targeted cancer cell imaging.71 The red fluorescent conjugated polyelectrolyte was 
grafted with dense PEG chains via click chemistry and modified with folic acid to 
obtain the molecular brush based cellular imaging probe. The conjugated 
polyelectrolytes were able to self-assemble into a core-shell nanomaterial in aqueous 
medium. The PEG chains could efficiently protect the fluorescent core to yield high 
quantum yield, leading to reduced nonspecific interactions with biomolecules in 
aqueous medium. The FR/NIR cellular probe allowed for effective visualization and 
discrimination of MCF-7 cancer cells from NIH/3T3 fibroblast cells with high 
sensitivity and selectivity. Wang et al. developed a self-assembled fluorescent 
aggregates based on cationic poly(fluorenylene phenylene) (PFP) with water-soluble 
lipids and ionic ammonium pendant groups as side chains to achieve cellular imaging 
as well as gene delivery.72 The hydrophobic polymer backbone and hydrophilic side 
chains facilitated self-assembly of fluorescent aggregates in aqueous solution with 
lipids and ammonium groups on surface. The employment of lipid facilitated the 
internalization of fluorescent probes into cell cytoplasm while the ammonium pendant 
groups of PFP side chains could interact with genes that offered the nanoaggregates as 
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a carrier for gene delivery. The cell imaging and plasmid delivery into lung cancer 
cells were successfully demonstrated. 
The hydrophobic backbones and ionic side chains of conjugated polyelectrolytes 
render them ability to interact with other materials through different mechanism. 
Besides the previous studies using water-soluble conjugated polymers for direct cell 
imaging, conjugated polyelectrolytes based complexes formed through electrostatic 
interaction with oppositely charged counterparts have also been explored. Liu et al. 
reported the synthesis of fluorescent nanoparticles with targeting ability using an 
anionic conjugated polyelectrolyte with energy donor-acceptor architecture to 
assemble with a positively charged Arg-Gly-Asp (RGD) terminated peptide.73 The 
schematic illustration is shown in Figure 2.5. Through changing the molar ratios 
between oppositely charged conjugated polyelectrolyte and peptide, fluorescent 
nanoparticles showed different sizes and fluorescence varying from sky-blue to 
orange-red due to the aggregation enhanced FRET from donor segments to acceptor 
units. Taking advantage of the specific binding affinity between RGD peptide and 
integrin receptors overexpressed in HT29 cancer cell membrane, the fluorescent 
nanoparticles served as an effective probe for targeted cancer cell imaging. In addition, 
these nanoparticles possessed low cytotoxicity and good photostability.  
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Figure 2.5 Schematic illustration of conjugated polymer/RGD peptide complex with 
targeting ability. Copyright American Chemical Society 2010. 
 
Considering the fact that most of the conjugated polymers are neutral, preparation of 
neutral conjugated polymer loaded nanoparticles (CP NPs) have attracted great interest 
in energy and biology studies. As compared to sophisticated synthetic procedures of 
conjugated polyelectrolytes, fabrication of CP NPs is a much easier way to prepare 
water-soluble conjugated polymer based fluorescent probes with tunable properties. 
Different groups have developed various synthetic routines to fabricate CP NPs, which 
include self-assembly, miniemulsion, matrix encapsulation and precipitation. 
Self-assembled CP NPs was firstly reported in 2008.74 The authors attached PEG as 
side chains to neutral conjugated polymer (PF) backbones to obtain amphiphilic 
rod-coil grafted polymers. After transfer into aqueous solution, the amphiphilic 
polymers formed core-shell nanoparticle structures with the compact fluorescent 
hydrophobic core and swollen PEG shell. The PEG shell rendered CP NPs good 
stability and biocompatibility. Through tuning the hydrophilic/hydrophobic ratio and 
molecular weight of the amphiphiles, CP NPs with different sizes were obtained. After 
incubation with BV-2 cells, the cell profiles could be obviously visualized and the 
cytotoxicity of CP NPs was very low.  
As compared to attachment of hydrophilic side chains to polymer backbones, in situ 
polymerization is a more commonly used method to synthesize stable CP NP aqueous 
dispersions. Kim et al. reported the direct synthesis of CPNs from in situ colloidal 
polymerization in aqueous phase without organic solvents.75 The hydrophobic 
monomers were firstly dissolved in Tween 80 aqueous solution to form stable micelles 
to allow base-catalyzed Knoevenagel polymerization to occur in the nanoscopic 
nonpolar interior of the micelles. The in vivo application of as-prepared CP NPs with 
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near infrared emission signature in real-time sentinel lymph node mapping was 
demonstrated in a mouse mode. Mecking et al. synthesized highly fluorescent CP NPs 
with different emission wavelengths in aqueous miniemulsion through Glaser coupling 
polymerization.76 The fluorescence properties of CP NPs were customized through 
covalent incorporation with fluorescent dyes during the polymerization to facilitate 
FRET and achieve desired emission wavelengths. CP NP aqueous dispersions with 
photoluminescence emission colors covering green to red were successfully 
synthesized. The same group further developed colloidally stable CP NPs using 
dibromo- and diethynyl-substituted benzenes and fluorenes in aqueous miniemulsion.77 
Through covalent incorporation of diethynyl pyrrolo-pyrrole or diethynyl fluorene in 
the polymerization, the emission color of these CP NPs could be fine-tuned from blue 
to orange due to energy transfer from the donor to the acceptor. The CP NPs showed 
efficient internalization into Hela cells without obvious adverse effect on the cells. 
Moreover, the obtained CP NPs possessed acceptable two-photon action cross sections, 
which could facilitate fluorescence imaging of the cells using two-photon excitation 
microscopy. 
Besides direct polymerization to obtain CP NPs, using pre-synthesized neutral 
conjugated polymer to prepared CP NPs stabilized by surfactant is another commonly 
used method. Green et al. synthesized PPV based CP NPs through miniemulsion 
method using poly(ethylene glycol) (PEG) as the surfactant.78 In this study, the 
solution of PPV in dichloromethane (DCM) was mixed with aqueous solution of PEG 
and the mixture was further sonicated in an ultrasonic bath to yield PEG coated CP 
NPs. The particle size could be well-controlled by using different PPV concentration in 
solution. HEp-2 cells showed intense fluorescent signal after incubation with PPV 
based nanoparticles, suggesting the efficient internalization into cell cytoplasm. The 
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same group further optimized the strategy to produce quantum-dot-sized PEG 
functionalized CP NPs.79 The incorporation of PEG-dithiol molecules in CP NPs was 
confirmed by mass spectrometry using sulfur as a reporter. The presence of PEG had 
significant effects on the yield of final production, suggesting its important role in CP 
NP formation.  
In 2010, Green et al. developed a general strategy to prepare a series of CP NPs using 
phospholipid as an encapsulation matrix through a solvent evaporation technique.80 In 
this study, four different conjugated polymers acted as hydrophobic fluorescent cores 
in which the hydrophobic segments of phospholipid embedded. The hydrophilic end of 
phospholipid oriented into water phase to render them good colloidal stability. The 
fluorescence imaging experiments using CP NPs indicated that these nanoparticles 
were internalized into SH-SY5Y neuroblastoma and living Hela cells. Surface 
amendable CP NPs were also obtained using carboxylic lipid-PEG as the matrix and 
further conjugation with BSA through typical carbodiimide-mediated chemistry 
indicated the potential application of such formulation in targeted imaging. A series of 
fluorescent-magnetic nanoparticles prepared through simultaneous encapsulation of 
conjugated polymer and iron oxide into phospholipid using the same strategy was 
further developed.81 The obtained nanoparticles showed promising magnetic properties 
but the quantum yields were quite low, which could be attributed to the fact that the 
direct interaction between conjugated polymer chains and iron oxide led to 
significantly quenched polymer fluorescence. 
Precipitation method is another feasible method to prepare CP NP suspensions. Moon 
et al. studied the formulation of CP NPs using amine-modified PPE prepared from 
phase-inversion precipitation in a poor solvent.82 The obtained CP NPs showed good 
cell imaging ability and exhibit higher photostability as compared to commercial 
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organic dye under continuous laser excitation at the same experimental conditions. The 
application of such CP NPs in two-photon imaging of endothelial cells in a tissue 
modal was also demonstrated, indicating their potential as promising multiphoton 
probes for biological and biomedical applications.83 Wu et al. explored a more feasible 
strategy in synthesizing CP NPs from nanoprecipitation method.84 The sizes of 
as-prepared nanoparticles could be controlled through changing the concentration of 
conjugated polymers. As compared to other fluorescent nanoparticles of similar size 
such as QDs, the CP NPs exhibited extraordinarily high fluorescence brightness, which 
will benefit the bioimaging applications. CP NPs with reasonable two-photon 
excitation cross-sections were also reported, holding great promises in two-photon 
excited fluorescence imaging. Taking advantage of the energy transfer between 
different conjugated polymers, FRET based CP NPs with large Stokes shift were 
synthesized to study the energy transfer mechanism. In 2008, the authors proposed a 
general strategy through nanoprecipitation to prepare CP NPs covering broad emission 
wavelengths.85 The CP NPs had small sizes, high fluorescence brightness and excellent 
photostability. Studying the photophysical properties of a single particle revealed that 
the CP NPs have much higher emission rates as compared to organic dyes and QDs. 
The application of such CP NPs in living cell imaging was also conducted after 
incubation with macrophages. 




Figure 2.6 Single-particle fluorescence images of (A) CP NP, (B) IgG-Alexa 488, and 
(C) Qdot 565, obtained under identical excitation conditions. Scale bar represents 5 μm. 
(D) Signal and background for single CP NP as compared to single IgG-Alexa 488 and 
single Qdot 565, observed under an identical excitation power of 1 mW. (E) Intensity 
distributions of single-particle fluorescence for the three probes under an excitation 
power of 4 mW. (F) Single-particle photobleaching trajectories. Copyright American 
Chemical Society 2010. 
 
After incorporating an amphiphilic polymer in the NP fabrication, the hydrophobic 
interaction among conjugated polymers and hydrophobic segments of the matrix 
resulted into CP NPs with surface hydrophilic groups.86 The surface functional groups 
allowed further conjugation with streptavidin and immunoglobulin G (IgG) to yield CP 
NP bioconjugates. The obtained bioconjugates were able to effectively label cell 
surface markers (EpCAM) in MCF-7 breast cancer cells with good specificity. Single 
particle imaging suggested that CP NPs possessed higher fluorescence brightness than 
                                                                       Chapter 2 
31 
 
Alexa 488 and Qdot 565 (Figure 2.6). Moreover, the single particle photobleaching 
trajectories revealed that blinking was not observed for CP NPs while frequent 
blinking was observed for Alexa 488 and Qdot 565.  
These active studies in exploration of CP NPs as cell imaging probes indicate that such 
novel class of fluorescent probes holds great promises in biological imaging 
applications. As the study of CP NPs for bioimaging applications is still at the early 
stage, more efforts should be made to boost the improvement of such fluorescent 
nanoparticles to satisfy rapid development of biological studies. 
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3. 1 Introduction 
Recently, the growing interest and booming development in biological detection 
motivate us to explore novel fluorescent probes with the hope to overcome the 
limitations in stability and cytotoxicity of conventional fluorescent reagents (eg., 
organic dyes and QDs) to satisfy highly sensitive assays. Conjugated polymers are 
macromolecules with π-conjugated backbones, which allow the formation of excitons 
to facilitate photo- and electroluminescence. Various conjugated polymers have been 
reported to show high extinction coefficient and high fluorescence.1 Due to their highly 
delocalized backbone structures and unique electronic and optical properties, 
conjugated polymers have been widely used for electronics and biosensor 
applications.2-5 Recently, the application of conjugated polymers for cellular imaging 
has also been reported.6-8 The main obstacle in the application of conjugated polymers 
for biosensors or cellular imaging is to render conjugated polymers good water 
solubility. One strategy is to introduce hydrophilic or ionic functional groups to 
conjugated polymers. The synthetic procedures generally require many steps, which 
are time-consuming. As compared to the sophisticated modification of polymer 
structures, an easier way is to prepare conjugated polymer based nanoparticles (CP 
NPs). By precisely controlling the experimental conditions, conjugated polymer based 
nanoparticles with different size can be prepared through nano-precipitation method, 
which show high fluorescence and little blinking.9-10 However, further encapsulation is 
necessary to provide these CP NPs with functional surface for bioconjugation and 
specific target detection. 
The purpose of this study is to develop a simple strategy which allows the formation of 
biocompatible and surface-functionalizable CP NPs in one step using 
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poly(DL-lactide-co-glycolide) (PLGA-COOH) as a matrix polymer. PLGA is one of 
the most widely used biocompatible polymers for preparing polymeric NPs in drug 
delivery system, which is reported to benefit the NP/cell interaction and enhance the 
cellular uptake efficiency.11 Formation of CP loaded PLGA NPs is conducted through a 
modified solvent extraction/evaporation single emulsion method with poly(vinyl 
alcohol) (PVA) as emulsifier.11 The excess terminal -COOH groups exposed to water 
allow further functionalization of the CP NPs. The synthesis of CP NPs and their 
application in cellular imaging are studied, which is followed by the demonstration of 
folic acid functionalized CP NPs for targeted cell imaging. As many neutral conjugated 
polymers have been reported in the literature with known optical properties, this 
strategy provides a general approach for preparing highly fluorescent and 
surface-amendable NPs with desired optical properties. 
3.2 Experimental Section 
3.2.1 Materials 
Poly[9,9-dihexylfluorene-alt-9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl) fluorene] 
(Mw = 30,000, PDI = 2.3), poly[9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl) 
fluorenyldivinylene-alt-9,9-bis(3-(t-butylpropanoate)fluorene] (Mw = 83,000, PDI = 
2.3), and 
poly[9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)fluorene-alt-4,7-(2,1,3-benzothiadia
zol)] (Mw = 36,000, PDI = 2.8) were synthesized according to the literature.12-13 
Poly[2-methoxy-5-(2'-ethyl-hexyloxy)-1,4-phenylene vinylene] (Mw > 50,000) was 
purchased from American Dye Source, Inc. Poly(DL-lactide-co-glycolide) 
(PLGA-COOH) (L:G molar ratio: 50:50, Mw: 100,000-130,000) was a gift from 
PURAC Asia Pacific, Singapore. Poly(vinyl alcohol) (PVA) (Mw: 30,000–70,000), 
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N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDAC), N- 
hydroxysuccinimide (NHS), N-hydroxysulfosuccinimide sodium salt (Sulfo-NHS), 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT),  
dicyclohexylcarbodiimide (DCC), penicillin-streptomycin solution, and trypsin-EDTA 
solution were purchased from Sigma-Aldrich. Fetal bovine serum (FBS) was 
purchased from Gibco (Lige Technologies, Ag, Switzerland). Dichloromethane (DCM) 
was obtained from Merck (Germany). Milli-Q water was supplied by Milli-Q Plus 
System (Millipore Corporation, Breford, USA). MCF-7 breast cancer cells and 
NIH/3T3 fibroblast cells were provided by American Type Culture Collection. 
3.2.2 Preparation of Nanoparticles  
The CP NPs were prepared through a modified solvent extraction/evaporation single 
emulsion method. A DCM solution (4 mL) containing 0.5 mg of CP and 50 mg of 
PLGA was poured into 60 mL of aqueous solution containing 0.5% (w/v) PVA as the 
emulsifier. This was followed by sonicating the mixture for 120 seconds at 18 W 
output using a microtip probe sonicator (XL2000, Misonix Incorporated, NY). The 
emulsion was then stirred at room temperature overnight to evaporate DCM. The 
formed NP suspension was washed by MilliQ water through centrifuging for three 
times to remove the excessive emulsifier and free CP molecules. The obtained NP 
suspension was frozen and freeze-dried for two days to get the fine powder of NPs.  
3.2.3 Characterization 
The fluorescence spectra of the CP NP aqueous suspensions were measured using a 
fluorometer (LS-55, Perkin Elmer, USA) with an excitation wavelength of 370 nm for 
PF loaded NPs, 407 nm for PFV loaded NPs, 458 nm for PFBT loaded NPs, and 488 
nm for MEH-PPV loaded NPs, respectively. The photograph of the CP NP aqueous 
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suspensions was taken using a digital color camera (EOS 400D, Canon, Japan) under a 
hand-held UV lamp with λmax = 365 nm. Average particle size and size distribution of 
the CP NPs were determined by laser light scattering (LLS) with particle size analyzer 
(90 Plus, Brookhaven Instruments Co. USA) at a fixed angle of 90° at room 
temperature. Zeta potential of the CP NPs was measured using zeta potential analyzer 
(ZetaPlus, Brookhaven Instruments Corporation) at room temperature. The surface 
morphology of CP NPs was investigated by field emission scanning electron 
microscopy (FESEM, JSM-6700F, JEOL, Japan) at an accelerating voltage of 10 kV. 
The NPs were fixed on a stub with a double-sided sticky tape and then coated with a 
platinum layer using an auto fine coater (JEOL, Tokyo, Japan) for 60s in a vacuum at a 
current intensity of 10 mA. The morphology of CP NPs was also studied by 
transmission electron microscope (TEM, JEM-2010F, JEOL, Japan). The surface 
chemistry of PFV loaded NPs and FA PFV loaded NPs was studied by X-ray 
photoelectron spectroscopy (XPS, AXIS His-165 Ultra, Kratos Analytical, Shimadzu 
Corporation, Japan). The fixed transmission mode was utilized with a pass energy of 
80 eV and the binding energy spectrum was recorded from 0 to 1100 eV. 
3.2.4 CP Encapsulation Efficiency 
The CP encapsulation efficiency is defined as the ratio of the amount of CP 
successfully encapsulated in CP NPs to the total amount of CP used in the fabrication 
of NPs. The fluorescence intensity of a series of DCM solution (1 mL) with designated 
CP concentration was analyzed using a fluometer (LS-55, Perkin Elmer, USA) upon 
excitation at the absorption maximum for each CP. The standard curve of fluorescence 
intensity of CP versus its concentration was then constructed. A certain amount (0.5 
mg) of freeze-dried CP NP powder was then dissolved in 1 mL of DCM and the 
fluorescence intensity at the maximum emission was obtained using the fluometer 
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upon excitation at the absorption maximum for each CP. The amount of CP 
encapsulated in 0.5 mg of CP NPs can be determined from the standard curve and the 
encapsulation efficiency was calculated. 
3.2.5 Calculation of CP Concentration 
When a mg of CP is used for preparation of CP loaded NPs with an encapsulation 
efficiency of b%, c mg of CP loaded NPs are obtained after freeze drying. If the CP 
loaded NPs were dispersed in 0.5c mL MilliQ water to yield [NP] = 2 mg/mL. The 
concentration of CP by polymer chain in the stock suspension can be calculated from 
the following equation: 
M    
mL 5.0M
%mg a           
 suspensionstock   theof VolumeM












In the cellular imaging and cytotoxicity experiments, the suspension was further 
diluted before use. 
3.2.6 In vitro CP Release from CP NPs 
To determine the stability of the CP NPs, 1 mg of NPs were suspended in 1 mL of 1× 
PBS buffer (PH 7.4) in a centrifuge tube and shaked at 37 °C in an orbital water bath 
shaker. At designated time intervals, the samples were centrifuged at 10,500 rpm for 
15 min. The supernatant of the samples was individually extracted with 1 mL of DCM 
and the fluorescence intensity of the DCM solution was monitored using a fluometer 
(LS-55, Perkin Elmer, USA) upon excitation at the absorption maximum for each CP. 
The NPs were resuspended in 1× PBS buffer and put back in the orbital water bath for 
continuous study. The percentage of released CP molecules was expressed as the 
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following equation:  






where NPInt  is the fluorescence intensity of CP prepared by dissolving 1 mg of dried 
CP NP powder in 1 mL of DCM solution. 
3.2.7 Folate Functionalization of PFV Loaded NPs 
Firstly, the amination of folic acid was carried out according to literature. In brief, folic 
acid (441.4 mg, 1 mmol) was reacted with DCC (247.6 mg, 1.2 mmol) and NHS 
(230.18 mg, 2 mmol) in 30 mL of DMSO for 6 h at 50 °C. The activated folic acid was 
then reacted with ethylene diamine (10 mmol) and pyridine (10 μg) at room 
temperature overnight. DCU was removed by filtration and the crude product was then 
precipitated by addition of excess acetonitrile, filtered and washed three times with 
diethyl ether. The aminated folic acid was collected after drying in a vacuum oven. 
The FA PFV loaded PLGA NPs was then prepared as follows: PFV loaded NPs (10 
mg) were dispersed in 5 mL of Mili-Q water. After addition of EDAC (0.32 mg) and 
Sulfo-NHS (0.36 mg), the PFV loaded PLGA NPs were activated for 2.5 h at room 
temperature. Borate buffer (5 mL, 0.2 M, PH = 8.5) was then added to the suspension, 
which was followed by the addition of 0.1 mL of aminated folic acid (0.1 M) in DMSO 
solution. The mixture was stirred at room temperature for 4 h and then washed with 
DMSO and water through centrifuging to eliminate the excess aminated folic acid. The 
FA PFV loaded NPs were then collected for further study. Under the similar conditions, 
PFV loaded NPs and aminated folic acid were mixed and stirred in the absence of 
EDAC and Sulfo-NHS. The obtained NPs were used as a control in the study of 
targeted cancer cell imaging. 
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3.2.8 Cell Cultures  
MCF-7 breast cancer cells and NIH/3T3 fibroblast cells were cultured in folate-free 
RPMI 1640 medium containing 10% fetal bovine serum and 1% penicillin 
streptomycin at 37 °C in a humidified environment containing 5% CO2. Before 
experiment, the cells were pre-cultured until confluence was reached. 
3.2.9 Cell Imaging  
MCF-7 cells were cultured in the chambers (LAB-TEK, Chambered Coverglass 
System) at 37 °C. After 80% confluence, the medium was removed and the adherent 
cells were washed twice with 1× PBS buffer. The PFV loaded NPs, FA PFV loaded 
NPs in RPMI 1640 medium at 87.5 nM PFV was then added to the chamber. After 
incubation for 2.5 h, cells were washed three times with 1× PBS buffer and then fixed 
by 75% ethanol for 20 minutes, which was further washed twice with 1× PBS buffer. 
The nuclei were stained with propidium iodide (PI) for 40 minutes. The cell monolayer 
was washed twice with 1×PBS buffer and imaged by confocal laser scanning 
microscope (CLSM, Zeiss LSM 410, Jena, Germany) with imaging software 
(Fluoview FV1000). The confocal images of NIH/3T3 cells treated with PFV loaded 
NPs or FA PFV loaded NPs under the same conditions were also studied. The confocal 
images of MCF-7 cancer cells were also obtained after treated with the other three 
types of CP NPs at 87.5 nM CP under the same conditions. 
3.2.10 Cellular Uptake  
MCF-7 cells were seeded into 96-well black plates (Costar, IL, USA) for quantitative 
study of cellular uptake. After the cells reached 80% confluence, the medium was 
replaced with the suspension of PFV loaded NPs, FA PFV loaded NPs in 100 μL of 
folate-free RPMI 1640 medium at 87.5 nM PFV. The cells were then cultured at 37 °C 
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for 2.5 h. For each sample, six wells were used for positive control without adding NP 
suspensions and another six wells were used for NP samples. After incubation for 2.5 h, 
the sample wells were washed three times with 50 µL 1× PBS buffer to remove traces 
of NPs. Folate-free RPMI 1640 medium (100 µL) was then added to each sample well, 
which was followed by addition of 50 µL of 0.5% Triton X-100 in 0.2 N NaOH to 
both positive control and sample wells to lyse the cells. The fluorescence intensity of 
NPs present in each well was then measured by microplate reader (Genios Tecan) with 
excitation wavelength of 407 nm. The fluorescence intensity was collected at 481 nm. 
The cellular uptake efficiency was expressed as the ratio of the fluorescence in the 
sample wells to that of the positive control. 
3.2.11 Cytotoxicity of CP NPs  
MTT assays were performed to assess the metabolic activity of NIH/3T3 fibroblast 
cells. NIH/3T3 cells were seeded in 96-well plates (Costar, IL, USA) at an intensity of 
4× 104 cells/mL. After 24 h incubation, the medium was replaced by the CP NP 
suspensions at CP concentrations of 87.5, 350, and 700 nM, and the cells were then 
incubated for 12, 24, and 48 h, respectively. After the designated time intervals, the 
wells were washed twice with 1×PBS buffer and 100 µL of freshly prepared MTT (0.5 
mg/mL) solution in culture medium was added into each well. The MTT medium 
solution was carefully removed after 3 h incubation in the incubator. Isopropanol (100 
µL) was then added into each well and the plate was gently shaken for 10 minutes at 
room temperature to dissolve all the precipitates formed. The absorbance of MTT at 
570 nm was monitored by the microplate reader (Genios Tecan). Cell viability was 
expressed by the ratio of absorbance of the cells incubated with NP suspension to that 
of the cells incubated with culture medium only.  
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3.3 Results and Discussion 
3.3.1 Characterization of CP NPs 
To demonstrate the generality of this strategy in preparing CP NPs, four polymers with 






azol)] (PFBT), and poly[2-methoxy-5-(2'-ethyl-hexyloxy)-1,4-phenylene vinylene] 
(MEH-PPV). The chemical structures of the polymers are shown in Scheme 3.1.  
 
Scheme 3.1 Chemical structures of PF, PFV, PFBT and MEH-PPV. 
 
Figure 3.1A and 3.1B shows the corresponding fluorescent color and the fluorescence 
spectra of the as-prepared CP NP aqueous suspensions. The emission maxima for PF, 
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respectively, which corresponds to blue, green, yellow, and red fluorescence. As 
compared to the fluorescence spectra of corresponding CP solutions in DCM (Figure 
3.1C), the maximum emission peaks of PF, PFV, PFBT and MEH-PPV loaded NP 
suspension are red-shifted by 9, 2, 3 and 37 nm, respectively. A similar red-shift is also 
observed when one compares the emission maximum of each CP film and that of the 
corresponding CP solution in DCM (Figures 3.1D and 3.1C). The red-shift of the 
maximum emission peaks for these NPs is mainly caused by aggregation of CP 
molecules upon NP formation, which increases the interactions between segments of 
polymer chains14 and favors energy transfer to low energy defects and weakly 
fluorescent aggregates.15 A similar red-shift is observed for conjugated polymer NPs 
prepared through nano-precipitation.15 These results indicate that the optical properties 
of CP NPs are mainly determined by the CP molecules loaded in the NPs, suggesting 
that CP NPs with unique optical properties can be achieved by utilizing specific CPs.  
 
Figure 3.1 (A) The photo of CP NP aqueous suspensions captured by digital camera 
under a hand-held UV lamp. Fluorescence spectra of (B) the CP NP aqueous 
suspensions, (C) the CP solutions in DCM and (D) the CPs in solid state (λex = 370 nm 
for PF, λex = 407nm for PFV, λex = 458 nm for PFBT, and λex = 488 nm for MEH-PPV).  
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Table 3.1 shows that the CP NPs have a volume average hydrodynamic diameter 
ranging from 243 to 272 nm, determined by the laser light scattering (LLS). PLGA 
encapsulated NPs with a similar size have been proven efficient for cellular uptake.11 
The zeta potential of CP NPs is measured to be larger than -30 mV. The value of zeta 
potential reflects the effective charge on the particle surface and is therefore related to 
the electrostatic repulsion among particles. The negative value of zeta potential for CP 
NP suspensions is due to the -COOH groups on the particle surface,16 which provide 
good colloidal stability for the NP suspensions. The CP encapsulation efficiency for 
these four types of CP NPs is ~ 45% by comparing the fluorescence intensity of the 
freeze-dried NPs dissolved in DCM to that of a calibration curve. The stability of the 
CP NPs is also studied by monitoring the amount of CP molecules released from the 
CP NPs suspended in PBS buffer at 37 °C. The amount of released CP molecules is 
obtained by centrifugation of the NP suspension and extracting the supernatant with 
DCM to monitor the fluorescence intensity. As shown in Table 2.1, the very low 
percentage of released CP molecules in 5 days indicates excellent stability of the CP 
NPs as compared to that of small molecule dye (coumarin-6) loaded PLGA NPs, which 
showed ~0.32% leakage in 24 h.17 The high stability can be attributed to the 
entanglement among the polymer chains of PLGA and CP, which blocks the diffusion 
of CP molecules into the aqueous phase. The extremely low release of CP molecules 








Table 3.1 Characteristics of the CP NPs 
 
a The particle size and polydispersity of NPs are determined by LLS. 
 
 
Figure 3.2 FESEM images of the (A) PF, (B) PFV, (C) PFBT and (D) MEH-PPV 
loaded PLGA NPs with PVA as emulsifier. 
 
The FESEM and TEM images of CP loaded NPs are shown in Figure 3.2 and Figure 
3.3. The FESEM images reveal that the CP NPs are in spherical shape with smooth 
surfaces and the NPs prepared from different CPs show similar surface morphology. In 
TEM images, the black dots indicate that the CP molecules are entangled and 
encapsulated in the PLGA matrix. The particle size observed from FESEM and TEM 
images is smaller as compared to that determined by LLS, which is mainly caused by 
A B
C D
 PF PFV PFBT MEH-PPV 
Particle size 
(nm)a 261.2 ± 4.5 257.5 ± 4.2 242.9 ± 3.8 271.4 ± 5.2 
Zeta potential 
(mV) -36.61 -37.15 -33.42 -35.28 
Encapsulation 
efficiency (%) ~41.3 ~43.9 ~44.2 ~47.6 
Leakage of CP 
in 5 days (%) <0.1 <0.1 <0.1 <0.1 
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the shrinkage of the polymeric NPs during the sample preparation in vacuum. Similar 
phenomenon has also been observed for other polymeric NPs.18 These results suggest 
that the solvent extraction/evaporation single emulsion method using PLGA as an 
encapsulation matrix is a general strategy to prepare various types of CP NPs with 
similar morphology. 
 
Figure 3.3 TEM images of the (A) PF, (B) PFV, (C) PFBT and (D) MEH-PPV loaded 
PLGA NPs with PVA as emulsifier. 
 
3.3.2 Application of CP NPs in Cellular Imaging 
The application of the as-prepared CP NPs in cellular imaging was studied by confocal 
laser scanning microscopy. In these experiments, the MCF-7 breast cancer cells were 
individually incubated in culture medium with different NP suspensions for 2.5 h at a 
CP concentration of 87.5 nM (based on polymer chain). The confocal images of 
MCF-7 cancer cells after incubation with different types of CP loaded PLGA NP 
suspensions are shown in Figure 3.4. Obvious fluorescence signal can be observed in 
cytoplasm around the nuclei, indicating that the CP loaded NPs are efficiently 
internalized into the cells to allow cell imaging.                                                  
A B
C D




Figure 3.4 Confocal images of the MCF-7 breast cancer cells after 2.5 h incubation 
with different CP NP suspensions at 87.5 nM conjugated polymer. 
 
3.3.3 Cytotoxicity of CP NPs 
The cytotoxicity of CP NPs was evaluated by metabolic viability of NIH/3T3 
fibroblast cells after incubation with the CP NPs. Figure 3.5 shows the cell viability 
after incubation with CP loaded NP suspension at CP concentrations of 700, 350, and 
87.5 nM for 12, 24 and 48 h, respectively. The metabolic viability of NIH/3T3 cells 
does not change after incubation with CP loaded NP suspension even at 700 nM PFV, 
indicating the low cytotoxicity of CP NPs to NIH/3T3 fibroblast cells within the tested 
period. Furthermore, unlike the concentration dependent cytotoxicity of QDs reported 
in the literature,19-20 the cytotoxicity of CP NPs is independent of NP concentrations, 
which is superior to QDs and can ensure their applications in real practice at high 
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Figure 3.5 Metabolic viability of NIH/3T3 fibroblast cells after incubation with the CP 
NP suspension at different CP concentrations for 12, 24 and 48 h, respectively. 
 
3.3.4 Targeted Cancer Cell Imaging  
The mechanism of cellular uptake for NPs can be affected by various factors, including 
the particle size, charge, and surface chemistry.21 One efficient method to improve 
cellular uptake and specific targeting effect of the NPs is to modify their surfaces with 
ligands which have specific interaction with the receptors over-expressed in the cell 
membrane. Folic acid has been widely used as a ligand to modify NPs to achieve 
cell-specific internalization via receptor mediated endocytosis for drug delivery and 
cellular imaging.22 It takes advantage of the high binding affinity (Kd ~ 100 pM) 
between folic acid and folate receptors which have low expression level in normal 
cells,23-24 but are over-expressed in several kinds of cancer cells such as breast, ovarian, 
kidney and prostate cancer cells. As a consequence, targeted MCF-7 breast cancer cell 
imaging can be realized using folic acid functionalized CP NPs, due to the much 
higher folate receptor expression level in the breast cancer cell membrane compared to 
that of NIH/3T3 fibroblast cells.25-26  




Scheme 3.2 Schematic representation of folic acid functionalization of the PFV loaded 
PLGA NPs. 
 










Binding Energy (eV)  
Figure 3.6 The XPS wide scan spectra of the PFV loaded NPs (red) and FA PFV 
loaded NPs (black). The inset shows the relative nitrogen signals at high resolution. 
 
The functionalization of PFV loaded NPs was carried out through EDAC-mediated 
coupling reaction between the –COOH groups of PLGA matrix and the amino groups 
of aminated folic acid, as illustrated in Scheme 2.2. The amination of folic acid was 
carried out according to literature.27 After functionalization, the zeta potential of PFV 
loaded NP aqueous suspension is decreased from -37.15 mV to -22.3 mV, which is due 
to the reduced carboxyl groups on the NP surface after conjugation with aminated folic 
acid. The presence of folic acid on NP surface is further confirmed by X-ray 
photoelectron spectroscopy (XPS), which provides the chemical composition of 
investigated particle surface. As shown in Figure 3.6, the peak at 397.6 eV in the 
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spectrum of folate-functionalized (FA) PFV loaded NPs indicates the presence of folic 
acid on the NP surface after conjugation as there is no nitrogen element in the pristine 
PFV loaded NPs.  
 
Figure 3.7 Confocal images of MCF-7 breast cancer cells incubated with the FA PFV 
loaded PLGA NP suspension at 87.5 nM PFV for 2.5 h. The cell nuclei were stained by 
propidium iodide (PI). The images were taken after continuously excitation at 405 nm 
(5% laser power) for 0 (A) and 20 min (B) with a band pass 465-495 nm filter. (C) 3D 
sectional confocal images of corresponding cells. 
 
Figure 3.7A shows the confocal image of the MCF-7 breast cancer cells after 
incubation for 2.5 h with the FA PFV loaded NP suspension in culture medium at 87.5 
nM PFV. The bright green fluorescence from NPs in cells remains clearly 
distinguishable after continuous laser excitation at 405 nm for 20 minutes (70% of the 
initial value, Figure 3.7B), indicating good stability of PFV loaded NPs. Under the 
same experimental conditions, much higher fluorescence intensity is shown in Figure 
3.7A as compared to that in Figure 3.4B. The result indicates that more FA PFV loaded 
NPs are internalized by MCF-7 cells via receptor mediated endocytosis. Quantitative 
studies reveal that the cellular uptake efficiencies for FA PFV loaded NPs and PFV 
loaded NPs are 47% and 31%, respectively. Moreover, 3D confocal image was also 
obtained, showing that the green fluorescence is mainly from the FA PFV loaded NPs 
internalized in the cell cytoplasm rather than from those on the cell surface (Figure 
3.7C). In addition, PFV loaded NPs treated with free aminated folic acid in the absence 
CA                                               B                                                
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of EDAC and Sulfo-NHS were also used as a control for cellular uptake studies of 
MCF-7 cancer cells. Figure 3.8 reveals that the green fluorescence intensity is similar 
to that for PFV loaded NPs shown in Figure 3.4B. These results suggest that the 
targeting effect of the FA PFV loaded NPs is due to the conjugation of folic acid onto 
the NP surface rather than the non-specific interaction between free folic acid and NPs.  
 
Figure 3.8 Confocal image of the MCF-7 breast cancer cells after 2.5 h incubation 
with the PFV loaded PLGA NP suspension treated with free aminated folic acid in 
culture medium at 87.5 nM PFV. The cell nuclei were stained by PI. 
 
As a low folate receptor control group, NIH/3T3 fibroblast cells were incubated with 
the suspensions of PFV loaded NPs and FA PFV loaded NPs for 2.5 h at 87.5 nM PFV, 
respectively. Figure 3.9 shows the confocal images of the NIH/3T3 cells after 
incubation. There is no obvious difference in green fluorescence intensity for NIH/3T3 
cells upon incubation with both NPs, mainly due to the low expression level of the 
folate receptor in NIH/3T3 cell membrane, which does not significantly favor 
internalization of the FA PFV loaded NPs. Meanwhile, comparison between Figure 
3.9B and Figure 3.7A indicates that the cellular uptake of FA PFV loaded NPs by 
NIH/3T3 fibroblast cells is much lower than that by MCF-7 cancer cells. These results 
suggest that the folic acid functionalization renders NPs targeting effect to cancer cells 
with over-expression of folate receptor in the membrane. Based on this understanding, 
the surface-functionalized CP NPs can provide helpful information in early cancer 





Figure 3.9 Confocal images of the NIH/3T3 fibroblast cells after 2.5 h incubation with 
the PFV loaded PLGA NP suspension (A) and FA PFV loaded PLGA NP suspension 
(B) in culture medium at 87.5 nM PFV. The cell nuclei were stained by PI. The images 
are obtained after continuous excitation at 405 nm (5% laser power) with a band pass 
465-495 nm filter.  
 
3.4 Conclusion 
We report a general method to fabricate CP loaded PLGA NPs through a solvent 
extraction/evaporation single emulsion method. The CP loaded PLGA NPs are of low 
cytotoxicity with high brightness and good photostability. Upon incubation of CP NPs 
with MCF-7 breast cancer cells, bright fluorescence was observed in cytoplasm around 
the nuclei. The PLGA matrix also allows further modification of NP surface with 
ligands for specific recognition of biological targets. Using PFV loaded NPs as an 
example, after functionalization of the PFV NPs with folic acid, the uptake of FA PFV 
NPs by MCF-7 cells was improved via receptor mediated endocytosis. Furthermore, 
the folate-functionalized NPs showed specific targeted imaging for MCF-7 breast 
cancer cells which had over expressed folate receptors in the membrane. Since this 
strategy provides a universal concept to prepare CP loaded NPs using hydrophobic CPs, 
multicolor and multifunctional CP loaded NPs with brighter fluorescence and better 
photostability could be achieved to satisfy the growing demands in biological 
A                                               B            
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application with the development of conjugated polymers. Further optimization of this 
one-step strategy using different matrix polymers is likely to yield CP NPs with 
desirable particle sizes that could meet the requirements for various biological 
applications.  
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Labelling and imaging of target cancer cells using fluorescent probes has become 
increasingly important in prognosis and treatment of cancer at the early stage.1-4 It is 
generally realized through conjugation of fluorescent probes with targeting moiety that 
has specific binding affinity to the antigen or receptor overexpressed in cancer cell.5 
Recently, CP based NPs have shown attractive merits over conventional fluorescent 
probes (eg., organic dyes and QDs) in terms of good photostability and low 
cytotoxicity, which are beneficial for cellular imaging studies.6-12 However, the main 
obstacle of the application of CP NPs in targeted cancer cell imaging is their limited 
surface functionalization.9,11 Although antibody or specific protein labeled probes have 
been proven very effective for targeted cellular imaging,5 so far there is no report that 
CP NPs have been functionalized with specific targeting proteins on surface. Another 
restriction of currently reported CP NPs is that most of them suffer from low quantum 
yields (QY) in aqueous solution, and in particular, green and red emission CP NPs 
were reported to have QYs of less than 0.02.7,8,11 The low QY is mainly due to π-π 
interaction upon NP formation that leads to CP aggregation and quenching of excited 
states.13-14 Development of CP NPs with high brightness, low cytotoxicity and tunable 
surface functionalization is of high importance to satisfy the booming development in 
targeted cellular imaging. 
In this contribution, we synthesize polyhedral oligomeric silsesquioxanes 
(POSS)-containing CP loaded PLGA NPs with high quantum yields and fine-tuned 
trastuzumab (Herceptin®) functionalization for Human Epidermal growth factor 
Receptor 2 (HER2)-positive cancer cell detection. The polymer design is inspired by 
previous studies that incorporation of POSS into CP side chains or as end cappers can 
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significantly increase the fluorescence quantum yield of the polymers.15-19 In addition, 
the commercially available octavinyl POSS also provides us the opportunity to 
synthesize hyperbranched POSS containing polymers in one step, where the steric 
hindrance effect of incorporated POSS could effectively prevent the fluorescent arms 
from close packing to form low-energy defects upon aggregation. The 
POSS-containing CP is encapsulated using a mixture of 
poly(lactic-co-glycolic-acid)-b-poly(ethylene glycol) (PLGA-b-PEG-NH2) block 
copolymer and PLGA-OCH3 in different molar ratio as matrix to yield CP NPs with 
well-controlled surface -NH2 groups. After subsequent conjugation with trastuzumab 
that has specific interaction with HER2, the functionalized CP NPs could be used to 
discriminate HER2-positive cancer cells from others. HER2-positive cancer cells are 
chosen as the target because the diagnosis of HER2 status becomes increasingly 
important in clinical cancer prognosis and treatment.20-23 As the HER2 expression level 
in HER2-positive breast cancer is significantly higher than that in other HER2-positive 
tumors,21 in this study, SKBR-3 breast cancer cell is selected as the model cell for 
HER2-positive cancer cell detection. 
4.2 Experimental Section 
4.2.1 Materials 
PLGA-COOH (L:G molar ratio: 50:50, Mw: 44,000) was a gift from PURAC Asia 
Pacific, Singapore. Amine-poly (ethylene glycol)-amine (PEG bisamine, Mw: 2,000) 
was purchased from Laysan Bio, Inc. Dimethyl sulfoxide (DMSO), PLGA-OCH3 (L:G 
molar ratio: 50:50, Mw: 40,000-75,000), PVA (Mw: 30,000–70,000), bovine serum 
albumin (BSA), EDAC, NHS, Sulfo-NHS, MTT, penicillin-streptomycin solution, 
dicyclohexylcarbodiimide (DCC), triethylamine (TEA), fluorescein isothiocyanate 
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isomer I (FITC) and Bradford reagent were purchased from Sigma-Aldrich. FBS, and 
trypsin-EDTA solution were purchased from Gibco (Lige Technologies, Ag, 
Switzerland). Trastuzumab (Herceptin®) was purchased from the National Cancer 
Center (Singapore). N,N-Dimethylformamide (DMF) and DCM was obtained from 
Merck (Germany). Milli-Q water was supplied by Milli-Q Plus System (Millipore 
Corporation, Breford, USA). SKBR-3 breast cancer cells, MCF-7 breast cancer cells, 
and NIH/3T3 fibroblast cells were provided by American Type Culture Collection. 
4.2.2 Synthesis of PFV and POSS-PFV 
Poly[9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl) fluorenyldivinylene] (PFV): A 
Schlenk tube was charged with 
2,7-dibromo-9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-9H-fluorene (130 mg, 
0.212 mmol), 9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-2,7-divinyl-9H-fluorene 
(108 mg, 0.211 mmol), Pd(OAc)2 (2 mg, 9 μmol) and P(o-tolyl)3 (15 mg, 49 μmol) 
before it was sealed with a rubber septum. The Schlenk tube was degassed with three 
vacuum-argon cycles to remove air. DMF (1.5 mL) and TEA (1 mL) was then added to 
the Schlenk tube and the mixture was frozen, evacuated, and thawed three times to 
further remove air. The polymerization was carried out at 100 °C under vigorous stir 
for 6 h. After cooling to room temperature, the mixture was filtered through 0.22 μm 
syringe driven filter and the filtrate was poured into ethyl ester. The precipitate was 
collected and dried under vacuum to afford PFV (160 mg, 78%) as green fibers. The 
number average molecular weight of PFV is 11, 000 with a polydispersity of 1.8. 1H 
NMR (400 MHz, CDCl3, δ ppm): 7.80-7.50 (m, 6 H), 7.29 (s, 2 H), 3.76-3.40 (m, 8 H), 
3.52 (s, 6 H), 3.29-3.19 (br, 4 H), 2.85 (br, 4 H), 2.50 (br, 4 H), 1.75 (br, 4 H).  
Polyhedral oligomeric silsesquioxanes-containing hyperbranched 
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poly[9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl) fluorenyldivinylene] (POSS-PFV): 
A Schlenk tube was charged with 
2,7-dibromo-9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-9H-fluorene (130 mg, 
0.212 mmol), 9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-2,7-divinyl-9H-fluorene 
(87 mg, 0.170 mmol), Pd(OAc)2 (2 mg, 9 μmol), and P(o-tolyl)3 (15 mg, 49 μmol) 
before it was sealed with a rubber septum. The Schlenk tube was degassed with three 
vacuum-argon cycles to remove air. DMF (1.5 mL) and TEA (1 mL) was subsequently 
added to the Schlenk tube and the mixture was frozen, evacuated, and thawed three 
times to further remove air. After reaction at 100 °C for 2 h, octavinyl POSS (14.0 mg, 
0.022 mmol) was added into the system. The polymerization continued at 100 °C 
under vigorous stir for additional 4 h. After cooling to room temperature, the reaction 
mixture was then filtered through 0.22 μm syringe driven filter and the filtrate was 
poured into acetone. The precipitate was collected and dried under vacuum to afford 
POSS-PFV (116 mg, 81%) as green fibers. The number average molecular weight of 
POSS-PFV is 17, 000 with a polydispersity of 1.9. 1H NMR (400 MHz, CDCl3, δ ppm):  
7.96-7.30 (m, 6 H), 7.33 (s, 2H), 6.28 (s, 0.08), 3.61-3.34 (m, 8 H), 3.28 (s, 4 H), 3.14 
(m, 6 H), 2.83 (br, 4 H), 2.46 (br, 4 H), 1.93 (br, 4 H). 
4.2.3 Preparation of Nanoparticles 
POSS-PFV loaded nanoparticles (PPNPs) were prepared through a modified solvent 
extraction/evaporation single emulsion method. A DCM solution (4 mL) containing 0.5 
mg of POSS-PFV and 50 mg of mixture of PLGA-PEG-NH2 and PLGA-OCH3 (molar 
percentage of PLGA-PEG-NH2 was 0, 5, 10, 20, and 30 %, respectively) was poured 
into 60 mL of aqueous solution containing 0.5% (w/v) PVA as the emulsifier. This was 
followed by sonicating the mixture for 120 seconds at 18 W output using a microtip 
probe sonicator (XL2000, Misonix Incorporated, NY). The emulsion was then stirred 
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at room temperature overnight to evaporate DCM. The formed NP suspension was 
washed by MilliQ water through centrifuging for three times to remove excessive 
emulsifier and free POSS-PFV molecules. PPNP0, PPNP5, PPNP10, PPNP20, and 
PPNP30 are assigned to PPNPs prepared with different molar percentages of 
PLGA-PEG-NH2. PFV loaded NPs with pure PLGA-OCH3 as encapsulation matrix 
were also prepared under the same experimental conditions. To prespare pure 
POSS-PFV NPs without encapsulation matrix, a DCM solution (4 mL) containing 0.5 
mg of POSS-PFV was poured into 60 mL of PVA aqueous solution, following the same 
procedure as that for the preparation of PPNPs. The preparation of bare NPs without 
encapsulating CP were carried out using the same method for the preparation of PPNPs. 
NP0, NP5, NP10, NP20, and NP30 represent NPs with different molar percentages of 
PLGA-PEG-NH2 added for NP formulation. 
4.2.4 Characterization  
The NMR spectra were collected on a Bruker ACF300 (300MHz) spectrometer. The 
fluorescence spectra of the CP NP aqueous suspensions were measured using a 
fluorometer (LS-55, Perkin Elmer, USA) with an excitation wavelength of 405 nm. 
Average particle size and size distribution of the CP NPs in water were determined by 
laser light scattering (LLS) with particle size analyzer (90 Plus, Brookhaven 
Instruments Co. USA) at a fixed angle of 90° at room temperature. The surface 
morphology of CP NPs was investigated by field emission scanning electron 
microscopy (FESEM, JSM-6700F, JEOL, Japan) at an accelerating voltage of 10 kV. 
The NPs were fixed on a stub with a double-sided sticky tape and then coated with a 
platinum layer using an auto fine coater (JEOL, Tokyo, Japan) for 60s in a vacuum at a 
current intensity of 10 mA.  
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4.2.5 Determination of POSS-PFV Encapsulation Efficiency  
The encapsulation efficiency of POSS-PFV is defined as the ratio of POSS-PFV 
successfully encapsulated in PPNPs to the total amount of POSS-PFV used in NP 
synthesis. The fluorescence intensity of a series of POSS-PFV solutions in DCM at 
479 nm was measured upon excitation at 405 nm. The standard curve of POSS-PFV 
fluorescence intensity versus concentration was then obtained. 0.5 mg of freeze-dried 
PPNPs powder was then dissolved in 1mL of DCM, and the fluorescence intensity at 
479 nm was obtained upon excitation at 405 nm. The amount of POSS-PFV 
encapsulated in 0.5 mg of NPs was then determined from the standard curve, and the 
encapsulation efficiency was calculated.  
4.2.6 Study of the Amount of -NH2 Groups on NP Surface  
A certain amount of bare NP (1 mg) was dispersed in borate buffer (1 mL, 0.2 M, PH = 
8.6). FITC (5 µL, 0.2 mg/mL) was then added into each sample and the mixtures were 
incubated at room temperature for 2 h to allow the reaction between isothiocyanate 
reactive groups of FITC and free -NH2 groups on NP surface. The samples were then 
washed for 3 times through centrifugation and the supernatant of each sample was 
collected and further diluted into a total volume of 3 mL. Then 100 µL of each 
supernatant was diluted into 1 mL of borate buffer, and the fluorescence intensity at 
524 nm was recorded using the fluometer upon excitation at 494 nm for FITC. The 
amount of FITC in the supernatant can be determined from the standard curve of 
fluorescence intensity of FITC versus its concentration, thus the amount of FITC 
reacted with -NH2 groups was further calculated to derive the relationship between the 
amount of -NH2 groups on NP surface and PLGA-PEG-NH2 feed ratio in NP 
formulation. 
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4.2.7 Determination of Trastuzumab Immobilized on NP Surface  
The conjugation of bare NPs with trastuzumab was carried out through EDAC 
coupling reaction. In brief, 0.5 mg of NP0, NP5, NP10, NP20, and NP30 were 
suspended in 1 mL of borate buffer (0.2 M, PH = 8.5), respectively. Trastuzumab, 
EDAC, and Sulfo-NHS were then added into each suspension at the stoichiometric 
molar ratio of PLGA-PEG-NH2/trastuzumab/EDAC/Sulfo-NHS = 1/1/5/5. The 
reaction was allowed to carry out overnight at room temperature with gentle 
end-to-end mixing. After conjugation of trastuzumab, the NPs were washed three times 
and the supernatant was collected for further analysis to obtain the concentration of 
trastuzumab in each supernatant via Bradford protein assay. The assay is based on the 
intensity of absorbance maximum of the Bradford reagent (an acidic solution of 
Coomassie Brilliant Blue G-250) at 595 nm upon binding to protein. The concentration 
of trastuzumab in each supernatant was determined using a standard curve. The 
amount of trastuzumb conjugated on each NP was further calculated as following: 
From Bradford protein assay, a mg of NP20 were conjugated with c mg of trastuzumab 
(Mw = 145531.5). The hydrodiameter of PPNP20 is d nm, as determined by LLS. As 
the NP in water suspension is stable, the density of NPs in suspension should be 
slightly higher than water and lower than PLGA in solid state (~1.25 g/cm3). We 
assume the density of NPs is ~1.1 g/cm3, so the number of trastuzumab conjugated on 
each NP can be calculated from the following equation: 
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4.2.8 Conjugation of PPNPs with Trastuzumab 
The conjugation of PPNPs with trastuzumab was carried out through EDAC coupling 
reaction under the same experimental condition as bare NP conjugation. HPPNP0, 
HPPNP5, HPPNP10, HPPNP20, and HPPNP30 represent corresponding PPNPs after 
conjugation with trastuzumab. Under the similar conditions, PPNP20 and trastuzumab 
were mixed and stirred in the absence of EDAC and Sulfo-NHS to obtain NPs as a 
control in the study of targeted breast cancer cell detection. 
4.2.9 Cell Cultures  
SKBR-3 breast cancer cells were cultured (37 °C, 5% CO2) in McCoy’s 5A medium 
containing 10% fetal bovine serum. MCF-7 breast cancer cells and NIH/3T3 fibroblast 
cells were cultured (37 °C, 5% CO2) in RPMI 1640 medium containing 10% fetal 
bovine serum and 1% penicillin streptomycin. Before experiment, the cells were 
pre-cultured until confluence was reached. 
4.2.10 Cytotoxicity of PPNPs  
MTT assays were used to assess the metabolic activity of NIH/3T3 fibroblast cells to 
study the cytotoxicity of PPNPs. NIH/3T3 cells were seeded in 96-well plates (Costar, 
IL, USA) at an intensity of 4× 104 cells/mL. After 24 h incubation, the medium was 
replaced by the PPNP0 or pure POSS-PFV NP suspension at a POSS-PFV 
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concentration of 8, 16, and 32 μg/mL, and the cells were then incubated for 24 and 48 
h, respectively. After the designated time intervals, the wells were washed twice with 
1× PBS buffer and 100 µL of freshly prepared MTT (0.5 mg/mL) solution in culture 
medium was added into each well. The MTT medium solution was carefully removed 
after 3 h incubation in the incubator at 37 °C. DMSO (100 µL) was then added into 
each well and the plate was gently shaken to dissolve all the precipitates formed. The 
absorbance of MTT at 570 nm was monitored by the microplate reader (Genios Tecan). 
Cell viability was expressed by the ratio of absorbance of the cells incubated with NP 
suspension to that of the cells incubated with culture medium only. To evaluate the 
cytotoxicity of PPNP5, PPNP10, PPNP20 and PPNP30, NIH/3T3 cells were incubated 
with each type of NP suspension at POSS-PFV concentrations of 32 μg/mL for 48 h, 
individually. The metabolic viability of NIH/3T3 cells was then evaluated, following 
the same procedure as that in the evaluation of the cytotoxicity of PPNP0. 
4.2.11 Uptake of Trastuzumab NPs by SKBR-3 Breast Cancer Cells  
SKBR-3 breast cancer cells were cultured in the confocal imaging chambers 
(LAB-TEK, Chambered Coverglass System) at 37 °C. After 80% confluence, the 
medium was removed and the adherent cells were washed twice with 1× PBS buffer. 
The HPPNP0, HPPNP5, HPPNP10, HPPNP20 and HPPNP30 in McCoy’s 5A medium 
at 4 µg/mL POSS-PFV were then added to the chambers, respectively. After incubation 
for 2 h, the cells were washed three times with 1× PBS buffer and then fixed by 75% 
ethanol for 20 minutes, which were further washed twice with 1× PBS buffer. The cell 
monolayer was imaged by confocal laser scanning microscope (CLSM, Zeiss LSM 
410, Jena, Germany) with imaging software (Fluoview FV1000) under the same 
experimental condition. 
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4.2.12 HER2 Detection in SKBR-3 Breast Cancer Cells  
Before the detection of HER2, SKBR-3, MCF-7, and NIH/3T3 cells were cultured in 
the chambers (LAB-TEK, Chambered Coverglass System) at 37 °C, respectively. After 
80% confluence, the adherent cells were washed twice with 1× PBS buffer and then 
fixed by 75% ethanol for 20 minutes, which were further washed twice with 1× PBS 
buffer and blocked for 30 min in 0.6 mL of 1× PBS containing BSA (2% BSA, 5 mM 
MgCl2). HPPNP20 (90 μL, 0.5 mg/mL) was then added into each well and the cells 
were further incubated for 20 min at 4 °C. The nuclei were then stained with PI for 20 
min. After washing with 1× PBS buffer (5 mM MgCl2), the cells were imaged by 
confocal laser scanning microscope (CLSM, Zeiss LSM 410, Jena, Germany) with 
imaging software (Fluoview FV1000). 
For living cell detection, SKBR-3, MCF-7, and NIH/3T3 cells were treated with 1× 
trypsin and washed with 1× PBS through centrifugation. The cell density was 
measured using a hemocytometer. Approximately 5 × 105 of each type of cells was 
blocked for 20 min in 1 mL of 1× PBS (2% BSA, 5 mM MgCl2). HPPNP20 (150 μL, 
0.5 mg/ml) was subsequently added into each sample and the cells were incubated for 
further 10 min at 4 °C. After incubation, the cells were washed with 1× PBS (5 mM 
MgCl2) through centrifugation at 1,500 rpm and finally resuspended in 0.5 ml of 1× 
PBS. For confocal imaging, a drop of cell suspension was placed on a glass slide and 
imaged immediately by confocal laser scanning microscope (CLSM, Zeiss LSM 410, 
Jena, Germany) with imaging software (Fluoview FV1000).  
4.3 Results and Discussion 
4.3.1 Synthesis and Characterization of POSS-containing CP 
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The monomers of 2,7-dibromo-9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-fluorene 
(1) and 9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-2,7-divinyl-fluorene (2) were 
synthesized according to our previous reports.24-25 1 and 2 were copolymerized via 
Pd(OAc)2/P(o-tolyl)3 catalyzed Heck coupling reaction in the mixture of DMF/TEA (3 : 
2) for 6 h to afford PFV. For POSS-PFV, octavinyl POSS was added into the reaction 
system after polymerization between 1 and 2 occurred for 2 h to induce hyperbranched 
architecture and the reaction continued for another 4 h. The synthetic entry to PFV and 
POSS-PFV is shown in Scheme 4.1. Attachment of PFV segments to the arms of POSS 
is verified by the presence of a single resonance peak at 6.28 in the 1H NMR spectrum 
of POSS-PFV, which is assigned to the protons near the silicon atoms of POSS (Figure 
4.1). Comparison of the integrated area between the peak at 6.28 ppm and that at 1.93 
ppm (the alkyl protons next to the 9-position of fluorene units) reveals that on average 
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Scheme 4.1 Synthetic entry to PFV and POSS-PFV.  




Figure 4.1 1H NMR spectra of PFV (A) and POSS-PFV (B). 
 
The absorption and emission maxima for POSS-PFV in film are 431 and 479 nm, 
respectively, which are blue-shifted by 4 and 2 nm as compared to that for PFV in film 
(Figure 4.2). The PL quantum yield of POSS-PFV in film is 0.2 (measured using 
quinine sulfate in 0.1 M H2SO4 as the standard), which is ~1.7 times higher than that 
for PFV in film (QY = 0.12). This is mainly due to the presence of POSS that can 
reduce π-π stacking and the chance of energy transfer to low-energy defects or weakly 
fluorescent aggregates.26 As a consequence, POSS-PFV loaded NPs (PPNPs) are 
expected to have a higher QY than that for PFV loaded NPs to benefit cell imaging.  
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Figure 4.2 Absorption and emission spectra of POSS-PFV (solid) and linear PFV 
(dash) in film (λex = 405 nm). 
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4.3.2 Synthesis and Characterization of CP NPs 
 
Scheme 4.2 Schematic illustration of CP NP synthesis through a modified solvent 
extraction/evaporation single emulsion method and subsequent conjugation to yield 
trastuzumab functionalized CP NPs. 
 
PLGA-b-PEG-NH2 block copolymer was synthesized from PLGA-COOH and 
PEG-bis(amine) according to literature.27 A modified solvent extraction/evaporation 
single emulsion method using a mixture of PLGA-b-PEG-NH2 and PLGA-OCH3 as 
encapsulation matrix was applied for the synthesis of PPNPs (Scheme 4.2).28 The 
amount of -NH2 groups on each NP surface is controlled by changing the molar ratio 
of PLGA-b-PEG-NH2 to PLGA-OCH3 at the feed for NP formulation. PPNP0, PPNP5, 
PPNP10, PPNP20 and PPNP30 represent PPNPs prepared with a feed molar ratio of 
0%, 5%, 10%, 20% and 30% for PLGA-PEG-NH2. To fabricate CP NPs, a DCM 
solution of POSS-PFV, PLGA-b-PEG-NH2 and PLGA-OCH3 was poured into PVA 
aqueous solution, followed by sonication using a microtip probe sonicator. The 
emulsion was stirred at room temperature overnight to evaporate DCM and washed to 
obtain NP suspension. Subsequent conjugation with trastuzumab in the presence of 
EDAC and Sulfo-NHS yielded the corresponding trastuzumab functionalized PPNPs 
(HPPNPs). The encapsulation efficiency of POSS-PFV for PPNP0 to PPNP30 was 44% 
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± 3% by studying the fluorescence intensity of the freeze-dried PPNPs dissolved in 
DCM against a standard curve. For comparison, pure POSS-PFV NPs in the absence of 
encapsulation matrix and PFV loaded NPs with PLGA-OCH3 as the encapsulation 
matrix were also prepared following the same procedure as that for PPNP0. 
4.3.3 Morphology 
 
Figure 4.3 FESEM images of PPNP0 (A), PPNP5 (B), PPNP10 (C), PPNP20 (D), 
PPNP30 (E), and PFV loaded NPs (F). 
 
LLS results suggest that PPNP0, PPNP5, PPNP10, PPNP20 and PPNP30 have volume 
average hydrodynamic diameters of 258 ± 5 nm, 243 ± 6 nm, 244 ± 5 nm, 235 ± 4 nm 
and 230 ± 3 nm, respectively. The FESEM images of the as-prepared PPNPs are 
shown in Figures 3.3A-E, indicating that the PPNPs have spherical shape and smooth 
surfaces. The relatively smaller particle size observed from FESEM images as 
compared to that from LLS is attributed to the polymeric nanoparticle shrinkage during 
sample preparation,29 which is also observed in our previous study of CP loaded PLGA 
NPs.9 Figure 4.3F shows the FESEM image of PFV loaded NPs, which have a very 
similar size and surface morphology to those of PPNP0. 
A                                            B                                                C
D                                                 E F
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4.3.4 Optical Properties 
The emission spectra of PPNP0 and PFV loaded NP suspensions in water at 1 mg/mL 
of NPs are shown in Figure 4.4. The emission maxima for PPNP0 and PFV loaded NP 
suspensions are 479 and 481 nm, respectively, which are similar to those for the 
corresponding CP films. The emission spectra of PPNPs prepared at different molar 
ratio of PLGA-b-PEG-NH2 to PLGA-OCH3 are very similar to each other. The 
quantum yields of PPNP0 and PFV loaded NPs in water are 0.19 and 0.11, respectively, 
which are consistent with those for POSS-PFV and PFV in film. The fluorescence 
spectra of PPNPs in 1× PBS buffer remained stable after being stored at 4 °C for one 
month. The physicochemical and optical properties of PPNPs are summarized and 
shown in Table 4.1. 
Table 4.1 Characteristics of the PPNPs 
 PPNP0 PPNP5 PPNP10 PPNP20 PPNP30 
Size (nm) 258 ± 5 243 ± 6 244 ± 5 235 ± 4 230 ± 3 
Zeta potential (mV) - 32.2 - 33.6 - 30.5 - 30.3 - 32.7 
Encapsulation 
efficiency (%) 43.4 45.2 42.7 43.9 44.5 
Quantu
m yield 
Water 0.19 0.18 0.19 0.19 0.20 
1× PBS 0.19 0.19 0.18 0.19 0.19 
λabs (nm)  432 431 432 433 432 
λem (nm)  479 479 478 479 477 
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Figure 4.4 Emission spectra for PPNP0 (solid) and PFV loaded NPs (dash) in water at 
[NP] = 1 mg/mL (λex = 405 nm).  
 
4.3.5 Cytotoxicity 
The cytotoxicity of PPNPs was evaluated by the metabolic viability of NIH/3T3 
fibroblast cells after incubation with PPNPs. Figure 4.5 shows the cell metabolic 
viability after incubation with PPNP0 at POSS-PFV concentrations of 8, 16, and 32 
µg/mL for 24 and 48 h, respectively. The metabolic viability of NIH/3T3 cells 
remained ~100% after incubation with PPNP0 suspension under the studied conditions, 
indicating low cytotoxicity of PPNP0. Similar results were also observed for PPNP5, 
PPNP10, PPNP20 and PPNP30 under the same experimental conditions. In addition, 
the metabolic viability of NIH/3T3 cells after incubation with pure POSS-PFV NPs 
without encapsulation matrix also did not show any obvious decrease under the same 
experimental condition (Figure 4.5). These results indicate that the CP NPs indeed 
have great potentials for cellular imaging applications. 























 PPNPs for 24h
 PPNPs for 48h
 Pure POSS-PFV NPs for 24h
 Pure POSS-PFV NPs for 48h
 
Figure 4.5 Metabolic viability of NIH/3T3 fibroblast cells after incubation with 
PPNP0 suspension and pure POSS-PFV NP suspension at different POSS-PFV 
concentrations for 24 and 48 h, respectively. 
 
4.3.6 Determination of Trastuzumab Density on NP Surface 
The targeting ligand density on NP surface plays an important role in cellular 
uptake.30-32 To quantify the number of trastuzumab on each NP, bare NPs with similar 
size and morphology as those of PPNPs were prepared without encapsulating 
POSS-PFV to avoid UV and PL interference from POSS-PFV on -NH2 and 
trastuzumab quantification. NP0, NP5, NP10, NP20 and NP30 represent bare NPs with 
the feed molar ratio of 0%, 5%, 10%, 20% and 30% for PLGA-PEG-NH2 in matrix, 
respectively. The effect of PLGA-PEG-NH2 feed ratio on NP surface -NH2 groups was 
studied with fluorescein isothiocyanate isomer I (FITC), by monitoring the 
fluorescence change of FITC solution before and after reaction with NP0 to NP30 and 
NP removal.33-34 The conjugation of trastuzumab to NPs was subsequently carried out 
through EDAC-mediated coupling reaction between trastuzumab (equal molar amount 
to that of PLGA-b-PEG-NH2 at the feed for NP formulation) and -NH2 groups on NP 
surface. The number of trastuzumab functionalized on NPs was studied by Bradford 
protein assay.35  
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The number of FITC molecules reacted with NP0 to NP30 shows almost a linear 
relationship with the feed molar ratio of PLGA-PEG-NH2 for NP formulation, 
suggesting that the amount of -NH2 groups on NP surface could be well-controlled by 
the feed molar ratio of PLGA-PEG-NH2 to PLGA-OCH3 during NP formulation 
(Figure 4.6). On the other hand, the Bradford protein assay results showed that the 
average numbers of trastuzumab on each NP were calculated to be 308 ± 21, 646 ± 35, 
1330 ± 42 and 2129 ± 68 for NP5, NP10, NP20 and NP30, respectively. The number of 
trastuzumab on NP surface increases with the increased amount of -NH2 on NP surface, 
indicating that the number of biomolecules conjugated on NP surface can be fine-tuned 
using PLGA-PEG-NH2 and PLGA-OCH3 as the NP building matrix.  

































Molar ratio of PLGA-PEG-NH2 in NP Preparation (%)  
Figure 4.6 The number of FITC molecules reacted with NP vs. the molar percentage of 
PLGA-PEG-NH2 in NP preparation.  
 
4.3.7 Uptake of Trastuzumab NPs by SKBR-3 Breast Cancer Cells 
The targeting ability of HPPNPs to HER2-positive cancer cells was studied using 
SKBR-3 breast cancer cells as an example because they are known to have 
overexpressed HER2. HPPNP0, HPPNP5, HPPNP10, HPPNP20 and HPPNP30 
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represent the corresponding PPNPs after functionalization with trastuzumab under the 
same experimental conditions as that for NP0 to NP30. We thus assume that the 
trastuzumab density on HPPNP5 to HPPNP30 follows the trend as that for NP5 to 
NP30.   
The effect of NP trastuzumab density on SKBR-3 breast cancer cell uptake was 
evaluated by confocal laser scanning microscopy. Figure 4.7 shows the confocal 
images of SKBR-3 breast cancer cells after incubation with HPPNP0, HPPNP5, 
HPPNP10, HPPNP20 and HPPNP30 suspension for 2 h in culture medium at 4 µg/mL 
POSS-PFV, respectively. These images were taken upon excitation at 405 nm (5% 
laser power) with a band pass 465–495nm filter. It is noteworthy that no auto 
fluorescence from the cell itself can be detected under the same experimental condition 
(Figure 4.7A). As shown in Figures 7B-E, the fluorescence intensity of SKBR-3 cancer 
cells increases with the increased trastuzumab density on NP surface and saturates 
upon incubation with HPPNP20 and HPPNP30. As a result, HPPNP20 is chosen for 
the detection of HER2-positive breast cancer cells. An enlarged image for cells in 
Figure 4.7E together with the 3D confocal image of cells incubated with HPPNP20 
show that the intense fluorescence is mainly from HPPNPs internalized in the SKBR-3 
cell cytoplasm (Figure 4.8). The higher fluorescence intensity of SKBR-3 cancer cells 
in Figures 3.7C-F as compared to that in Figure 4.7B suggests that more NPs are 
internalized into the cells via receptor mediated endocytosis, which is due to the 
specific binding affinity between HER2 in SKBR-3 cell membrane and trastuzumab 
immobilized on NP surface.36-37  




Figure 4.7 (A) Confocal image of SKBR-3 breast cancer cells. (B-F) Confocal images 
of SKBR-3 cells after 2 h incubation with HPPNP0 (B), HPPNP5 (C), HPPNP10 (D), 
HPPNP20 (E) and HPPNP30 (F) suspension at 4 µg/mL POSS-PFV, respectively. The 
scale bars of images B-F are the same as that of image A. 
 
  
Figure 4.8 Enlarged confocal image of Figure 4.7E (left) and 3D sectional confocal 
image (right) for SKBR-3 breast cancer cells upon incubation for 2 h with HPPNP20 
suspension at 4 µg/mL POSS-PFV.  
 
To further confirm that the enhanced uptake of HPPNPs is due to the trastuzumab 
immobilized on NP surface, PPNP20 treated with free trastuzumab in the absence of 
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SKBR-3 breast cancer cells. The confocal image shown in Figure 4.9 reveals that the 
green fluorescence intensity is similar to that of Figure 4.7B, indicating that the 
targeting effect of HPPNPs is derived from the trastuzumab conjugated on NP surface 
rather than that from the non-specific interaction between free trastuzumab and NPs. 
 
Figure 4.9 Confocal image of SKBR-3 breast cancer cells after 2 h incubation with 
HPPNP20 suspension treated with free trastumumab in culture medium at 4 µg/mL of 
POSS-PFV. 
 
4.3.8 HER2-positive Cancer Cell Detection 
SKBR-3 breast cancer cells were used as HER2-positive cancer cells while MCF-7 
breast cancer cells and NIH/3T3 fibroblast cells were used as the negative control 
which lack HER2 expression. The detection of HER2-positive cancer cells was 
demonstrated by staining HER2 in cell membrane of both fixed cells on substrate and 
live cells in aqueous suspension at 4 °C. Previous studies show that fluorescent probes 
only specifically stain the cell membrane without internalization under these 
conditions.38-39 
Figures 3.10A-C show the confocal images of fixed SKBR-3, MCF-7 and NIH/3T3 
cells after incubation with HPPNP20 for 20 min at 4 °C in the presence of 1.04 µg/mL 
POSS-PFV (65 µg/mL of HPPNP20). The fluorescence/transmission overlapped 
images of corresponding cells are shown in Figures 3.10D-F. The cell nuclei are 
30μm
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stained by propidium iodide (PI). The strong and regular green fluorescent profile of 
SKBR-3 breast cancer cells (Figure 4.10A) indicates that the cell membrane has been 
successfully stained by HPPNP20. On the contrary, only weak and randomly 
distributed fluorescent signal can be detected from MCF-7 and NIH/3T3 cell 
membrane under the same experimental condition (Figures 3.10B-C). Thus, the 
specific interaction between trastuzumab on NP surface and HER2 in cell membrane 
allows clear discrimination of HER2-positive cancer cells.  
 
Figure 4.10 Confocal images of fixed SKBR-3 breast cancer cells (A), MCF-7 breast 
cancer cells (B) and NIH/3T3 fibroblast cells (C) stained with HPPNP20 (65 µg/mL) 
for 20 min at 4 °C. (D-F) are the fluorescence/transmission overlapped images of the 
corresponding cells. The cell nuclei were stained by PI. The scale bars of images B-F 
are the same as that of image A. 
 
The specific interaction between HPPNPs and HER2 was further investigated by these 
three types of live cells. Figure 4.11 shows the confocal images of the live cell 
suspensions treated with HPPNP20 for 10 min at 4 °C with 1.04 µg/mL POSS-PFV 
(65 µg/mL of HPPNP20). The bright green circles in Figure 4.11A suggest that the 
SKBR-3 cells are successfully labeled by HPPNP20. On the other hand, much lower 
fluorescence is detected from MCF-7 and NIH/3T3 cells in Figures 3.11B and 3.11C, 
30 μm
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respectively. Moreover, the confocal image of SKBR-3 breast cancer cells after 
incubation with PPNP20 under the same experimental condition was also obtained and 
shown in Figure 4.12. No obvious fluorescent signal was detected on the cell surface, 
indicating low non-specific interaction between PPNP20 and cell membrane. These 
results suggest that HPPNP20 can serve as a specific fluorescent probe for 
HER2-positive cancer cell detection.  
 
Figure 4.11 Confocal images of different types of suspended live cells stained with 
HPPNP20 (65 µg/mL) for 10 min at 4 °C: (A) SKBR-3 breast cancer cells, (B) MCF-7 
breast cancer cells and (C) NIH/3T3 fibroblast cells. (D-F) are the 
fluorescence/transmission overlapped images of the corresponding cells. The scale 
bars of images B-F are the same as that of image A. 
 
 
Figure 4.12 Confocal images of SKBR-3 breast cancer cell suspension after staining 
with PPNP20 (65 µg/mL) for 10 min at 4 °C. 
 
80 μm
A                                                B                                               C                           
D                                                E                                               F




POSS-PFV loaded NPs with high PL quantum yield, excellent stability, low 
cytotoxicity and tunable surface protein density have been synthesized for 
HER2-positive cancer cell detection. The use of a mixed encapsulation matrix 
composed of PLGA-b-PEG-NH2 and PLGA-OCH3 at different molar ratio allows 
control of the -NH2 groups on NP surface. Subsequent conjugation with trastuzumab 
yields target protein functionalized NPs that can significantly increase their uptake by 
SKBR-3 breast cancer cells. The specific binding affinity between trastuzumab 
functionalized POSS-PFV loaded NPs and SKBR-3 breast cancer cells over MCF-7 
breast cancer cells indicates that the POSS-PFV loaded NPs have great potentials in 
specific HER2-positive cancer cell detection. By designing different specific protein 
functionalized CP NPs with tunable emission wavelength, simultaneous detection of 
multiple biological targets under single laser excitation is achievable in near future. 
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CONJUGATED POLYMER LOADED NANOPARTICLES 
WITH SURFACE FUNCTIONALIZATION FOR 
DISCRIMINATION OF DIFFERENT LIVE CANCER 












As compared to single target detection, simultaneous differentiation of two or more 
biosubstrates, especially under single laser excitation, becomes increasingly important 
due to the reduction in instrument complexity, sample volume, test time, and overall 
cost.1-5 Multicolor fluorescent proteins and other biomolecules, such as catecholamines 
and indolamines, are native fluorescent probes that have been explored to 
simultaneously study subcellular domains.1,6 These fluorescent biomolecules generally 
have distinct absorption spectra, which often lead to low excitation efficiency under 
single laser excitation with compromised sensitivity in multiplex detection assays.7-8 In 
addition, poor photostability has been reported for fluorescent biomolecules, which 
further reduces their long term applications.4 To achieve multiple-target detection 
under single laser excitation with high resolution, the probes have to possess similar 
absorption but distinct emission wavelengths. Surface functionalized inorganic 
semiconductor QDs have been used for multiplex imaging by taking advantage of their 
broad excitation spectra and narrow emission bands.9-10 However, the intrinsic 
cytotoxicity of QDs caused by the released heavy metal ions in oxidative environment 
remains an issue for both in vivo and in vitro studies.11 Recently, multicolor silica 
nanoparticles which encapsulate different organic dye molecules have also been 
reported.12-14 The small Stokes shift of dye molecules and the emission spectrum 
overlap among different dyes often lead to signal interference among dye doped 
nanoparticles when excited at a single wavelength.13 Moreover, for multiple-dye doped 
silica nanoparticles, the doping ratio among different dyes needs to be precisely 
controlled in order to achieve desired fluorescent nanoparticles and to avoid 
batch-to-batch variations, which further increases complexity and reduces 
reproducibility of the assays. The inherent shortcomings of fluorescent proteins, QDs 
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and dye doped nanoparticles have motivated researchers to explore novel fluorescent 
probes with low toxicity, similar absorption maxima and minimal emission spectral 
overlap for simultaneous multiple-target imaging and detection. 
Conjugated polymers have distinguished advantages over small molecular organic 
dyes in terms of high extinction coefficient, efficient interchain/intrachain exciton 
migration, and good photostability.15-17 Recent studies reveal that a small number of 
optically active units within a polymer backbone could be activated by structural 
changes that compressed or aggregated the overall polymer sample.18 On the basis that 
three-dimensional interchain energy transfer could be more efficient than 
one-dimensional intrachain transfer,19-20 we and others have developed a series of 
multicolor conjugated polymers with energy donor-acceptor backbones, which exhibit 
aggregation-enhanced acceptor emission with large apparent Stokes shifts upon 
excitation of the donor.21-24 This special optical feature provides an opportunity to 
design polymers with a similar absorption but different emission colors in the solid 
state simply by fine-tuning the content of acceptors in the polymer backbone.25-26 
Based on the fact that conjugated polymer loaded nanoparticles (CP NPs) have shown 
similar optical properties to their respective conjugated polymers in the solid state,27-30 
the energy donor-acceptor conjugated polymer design thus provides a new opportunity 
to fabricate fluorescent nanoparticles with different emission colors upon excitation at 
the same donor units. To the best of our knowledge, very few fluorescent probes could 
be designed to have exactly the same absorption maximum, but with distinct emission 
spectra. In addition, CP NPs could be designed to have high fluorescence due to the 
light harvesting property of conjugated polymers. 
In this contribution, we synthesize affibody or arginine-glycine-aspartic acid (RGD) 
peptide functionalized CP NPs for simultaneous detection of human epidermal growth 
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factor receptor 2 (HER2) positive and integrin positive cancer cells under single laser 
excitation. The conjugated polymers used in this study are 
poly[9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl) fluorenyldivinylene] (PFV) and the 
PFV derivative (PFVBT) containing 10 mol% 2,1,3-benzothiadiazole (BT). Such a 
molecular design is expected to yield CP NPs with distinctive emission upon excitation 
of the fluorenylvinylene units. As the diagnosis of HER2 status is of high importance 
in personalizing cancer treatment and integrin receptors play a key role in cancer cell 
growth as well as cancer matastasis and tumorigenesis,31-33 anti-HER2 affibody and 
RGD peptide that have specific targeting ability to HER2 and integrin receptors, 
respectively, are used to modify the nanoparticle surface.34-35 The anti-HER2 affibody 
rather than anti-HER2 antibody is chosen as the targeting ligand to HER2 receptor 
because affibody molecules are engineered to imitate monoclonal antibodies, which 
possess valuable advantages over antibodies in terms of specificity, small size and high 
stability.36-38 At last, we demonstrate that the obtained nanoparticles allow for 
simultaneous detection of HER2 positive cancer cells and integrin receptor positive 
cancer cells in one mixture.  
5.2 Experimental Section 
5.2.1 Materials 
Poly[9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl) fluorenyldivinylene] (PFV) was 
synthesized according to literature.30 PLGA-COOH (L:G molar ratio: 50:50, Mw: 
44,000) was a gift from PURAC Asia Pacific, Singapore. Poly(vinyl alcohol) (Mw: 
30,000–70,000), EDAC, Sulfo-NHS, THF, MTT, and TEA were purchased from 
Sigma-Aldrich. FBS, penicillin-streptomycin solution, and trypsin-EDTA solution 
were purchased from Gibco (Lige Technologies, Ag, Switzerland). 
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Arginine-glycine-aspartic (RGD) acid peptide (RGDKKKKKK) was a customized 
product from 1st Base, Singapore. Anti-HER2 affibody was a commercial product 
from Affibody AB, Sweden. DMSO, DMF and DCM were obtained from Merck 
(Germany). Milli-Q water was supplied by Milli-Q Plus System (Millipore 
Corporation, Breford, USA). NIH/3T3 fibroblast cells, SKBR-3 breast cancer cells, 
and HT-29 human colon adenocarcinoma cells were provided by American Type 
Culture Collection. 
5.2.2 Synthesis of PFVBT 
2,7-Divinyl-9,9(-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)fluorene (1) and 
2,7-dibromo-9,9(-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)fluorene (2) were first 
synthesized according to our previous reports.39-40 A Schlenk tube was charged with 1 
(110 mg, 0.215 mmol), 2 (106.3 mg, 0.172 mmol), 4,7-dibromo-2,1,3-benzothiadiazole 
(12.7 mg, 0.043 mmol), Pd(OAc)2 (2 mg, 9 µmol), and P(o-tolyl)3 (15 mg, 49 µmol) 
before it was sealed with a rubber septum. The Schlenk tube was degassed with 
vacuum-argon cycles to remove air. Then, DMF (2 mL) and TEA (1 mL) were 
subsequently added to the Schlenk tube and the mixture was frozen, evacuated, and 
then thawed three times to further remove air. The mixture was stirred and heated to 
100 °C for 2 hours under argon. After the mixture was cooled down to room 
temperature, 50 mL of DCM was added and the organic layer was washed with 25 mL 
of water, followed by drying over anhydrous MgSO4. After filtration and solvent 
removal, the residue was poured into 100 mL of diethyl ether. The precipitate was 
collected and dried under vacuum for 24 h to afford PFVBT (113 mg, 58 %) as red 
fibers. 1H NMR (400 MHz, CDCl3, δ ppm): 7.71 -7.27 (m, ~8.4 H), 3.53-3.27 (m, 12 
H), 3.20 (br, 6H), 2.86 (br, 4 H), 2.50 (br, 4 H), 1.85 (br, 4 H).  
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5.2.3 Preparation of CP NPs 
The CP NPs were prepared through a solvent extraction/evaporation single emulsion 
method. A DCM solution (6 mL) containing 1 mg of CP and 50 mg of PLGA was 
poured into 60 mL of aqueous solution containing 1% (w/v) poly(vinyl alcohol) as the 
emulsifier. The mixture was sonicated for 120 seconds at 20 W output using a microtip 
probe sonicator. The emulsion was then stirred overnight to evaporate DCM. The NP 
suspension was washed with MilliQ water through centrifuging for three times to 
remove the excessive emulsifier and free polymers. The obtained PFV loaded NP 
(PFVNP) and PFVBT loaded NP (PFVBTNP) suspensions were filtered through a 0.45 
μm syringe filter and kept at 4 °C for further use. Bare NPs without CP encapsulation 
were also prepared following the same method for the fabrication of CP NPs. 
5.2.4 Determination of PFV and PFVBT Encapsulation Efficiency 
The encapsulation efficiency of CP is defined as the ratio of CP successfully 
encapsulated in CP loaded NPs to the total amount of CP used in NP formulation. For 
PFV, the fluorescence intensity of a series of PFV solutions in DCM at 467 nm was 
measured upon excitation at 405 nm to yield a standard curve of PFV fluorescence 
intensity versus concentration. The freeze-dried PFVNPs powder (0.5 mg) was then 
dissolved in 1 mL of DCM, 50 μL of which was diluted into 1 mL of DCM and the 
fluorescence intensity at 467 nm was obtained upon excitation at 405 nm. The amount 
of PFV encapsulated in 0.5 mg of NPs was then determined from the standard curve, 
and the encapsulation efficiency was further calculated. The similar experiments were 
carried out for determination of PFVBT encapsulation efficiency in PFVBTNPs. 
5.2.5 Cytotoxicity of PFVNPs and PFVBTNPs 
MTT assays were used to assess the metabolic activity of NIH/3T3 fibroblast cells to 
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study the cytotoxicity of PFVNPs and PFVBTNPs. NIH/3T3 cells were seeded in 
96-well plates (Costar, IL, USA) at an density of 4× 104 cells/mL. After 24 h 
incubation, the medium was replaced by the PFVNP or PFVBTNP suspension at 
concentrations of 900, 1800, and 3600 μg/mL, and the cells were then incubated for 
further 48 h, respectively. After the designated time intervals, the wells were washed 
twice with 1× PBS buffer and 100 µL of freshly prepared methylthiazolyldiphenyl 
tetrazolium bromide (0.5 mg/mL) solution in culture medium was added into each well. 
The methylthiazolyldiphenyl tetrazolium bromide medium solution was carefully 
removed after 3 h incubation in the incubator at 37 °C. DMSO (100 µL) was then 
added into each well to dissolve all the precipitates formed. The absorbance of 
methylthiazolyldiphenyl tetrazolium bromide at 570 nm was measured by the 
microplate reader (Genios Tecan). Cell viability was expressed by the ratio of 
absorbance of the cells incubated with CP NP suspension to that of the cells incubated 
with culture medium only.  
5.2.6 Surface Functionalization of CP NPs  
To synthesize affibody functionalized CP NPs, PFVNPs or PFVBTNPs (0.5 mg) were 
first dispersed in 0.5 mL of Milli-Q water. After the addition of EDAC and Sulfo-NHS 
into the solution at the stoichiometric molar ratio of -COOH/EDAC/Sulfo-NHS = 
1/10/10, the carboxyl groups on NP surface were activated for 2 h. Borate buffer (0.5 
mL, PH = 8.5) was then added to the suspension, which was followed by the addition 
of affibody solution (30 μL, 1 mg/mL). The mixture was stirred for 3 h and then 
washed with water through centrifugation to remove the excess affibody. The 
APFVNPs or APFVBTNPs were then collected for further study. To synthesize RGD 
peptide functionalized NPs, PFVNPs or PFVBTNPs (0.5 mg) were first dispersed in 1 
mL of 0.1× PBS. RGDKKKKKK solution (10 μL, 10-3 mol/L) was then added into the 
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NP suspension and gently mixed for 2 h. After centrifugation to remove the excess 
peptide, the RPFVNPs and RPFVBTNPs were collected for further study. All the 
experiments were carried out at 4 °C. 
5.2.7 Characterization  
The NMR spectra were collected on a Bruker ACF300 (300MHz) spectrometer. GPC 
analysis was conducted with a Waters 2690 liquid chromatography system equipped 
with Waters 996 photodiode detector and Phenogel GPC columns. The molecular 
weight and polydispersity were determined using polystyrenes as the standard and 
THF as the eluent at a flow rate of 1.0 mL/min at 35 °C. UV-Vis spectra were recorded 
on a Shimadzu UV-1700 spectrometer. The fluorescence spectra of the PFVNP and 
PFVBTNP aqueous suspensions were measured using a fluorometer (LS-55, Perkin 
Elmer, USA). Average particle sizes of the nanoparticles were determined by laser 
light scattering with particle size analyzer (90 Plus, Brookhaven Instruments Co. USA) 
at a fixed angle of 90° at room temperature. Zeta potential of the nanoparticles was 
measured using zeta potential analyzer (ZetaPlus, Brookhaven Instruments 
Corporation) at room temperature. The morphology of CP loaded NPs was studied by 
transmission electron microscope (TEM, JEM-2010F, JEOL, Japan). The surface 
chemistry of APFVNPs and RPFVBTNPs was studied by X-ray photoelectron 
spectroscopy (XPS, AXIS His-165 Ultra, Kratos Analytical, Shimadzu Corporation, 
Japan). The fixed transmission mode was utilized with a pass energy of 80 eV and the 
binding energy spectrum was recorded from 0 to 1100 eV. The photos of CP loaded 
nanoparticles aqueous suspensions were taken using a digital color camera (EOS 450D, 
Canon, Japan) under a hand-held UV lamp with λmax = 365 nm. 
5.2.8 Determination of Ligands Functionalized on NP Surface  
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The modification of bare NPs with affibody or RGD peptide was carried out using the 
same methods for surface functionalization of CP loaded NPs. After conjugation with 
affibody, the NPs were washed three times and the supernatant was collected for 
further analysis to obtain the concentration of affibody in supernatant via Bradford 
protein assay. Based on the intensity at the absorption maximum of the Bradford 
reagent (an acidic solution of Coomassie Brilliant Blue G-250) at 595 nm upon 
binding to protein, the concentration of affibody in supernatant was determined using a 
standard curve. The amount of affibody conjugated on each NP was further calculated 
as the ratio of the total number of immobilized affibody to the total number of NPs.  
For NPs treated with RGD peptide, the NPs were washed three times and the 
supernatant was collected to quantify the peptide in supernatant via fluorescamine 
assay. The supernatant (0.5 mL) was mixed with borate buffer (0.5 mL, PH = 8.6), 
followed by the addition of fluorescamine solution in acetone (5 mg/mL, 10 μL). The 
fluorescence intensity at 485 nm was monitored upon excitation at 390 nm. Similarly, a 
standard curve was formed by plotting the solution fluorescence intensity for 
fluorescamine upon reacting with the peptide of known concentrations. The peptide 
concentration in supernatant was determined from the standard curve and the amount 
of RGD peptide on each NP was further calculated as the ratio of the total peptide 
immobilized peptide to the total number of NPs. Detailed calculation is described as 
following: 
From Bradford protein assay or fluorescamine assay, 0.5 mg of bare NPs were 
successfully functionalized with a mg of affibody (Mw = 14000) or b mmol of RGD 
peptide. The hydrodynamic diameter of bare NPs is d nm. As the NPs are stable in 
water, the density of NPs should be slightly higher than water and lower than 
poly(lactic-co-glycolic-acid) in solid state (~1.25 g/cm3). We assume the density of 
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NPs is ~1.1 g/cm3, so the numbers of affibody or RGD peptide conjugated on each NP 
can be calculated from the following equation: 
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5.2.9 Cell Cultures  
SKBR-3 breast cancer cells and HT-29 human colon adenocarcinoma cells were 
cultured in McCoy’s 5A medium and DMEM medium containing 10% fetal bovine 
serum at 37 °C in a humidified environment containing 5% CO2, respectively. Before 
experiment, the cells were pre-cultured until confluence was reached. 
5.2.10 Staining of Live SKBR-3 Cells or HT-29 Cells in Suspension  
SKBR-3 or HT-29 cells were treated with 1× trypsin and washed with 1× PBS through 
centrifugation. The cell density was measured using a hemocytometer. Approximately 
5 × 105 of SKBR-3 or HT-29 cells were dispersed in 1 mL of 1× PBS (5 mM MgCl2), 
respectively. APFVNPs or RPFVBTNPs (150 μL, 0.5 mg/ml) were added into each 
cell suspension. The cells were washed with 1× PBS (5 mM MgCl2) through 
centrifugation at 1,500 rpm after incubation for 10 min, and finally suspended in 0.5 
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mL of 1× PBS. All the procedures were carried out at 4 °C. For confocal imaging, cell 
suspension was dropped on a glass slide and imaged immediately by confocal laser 
scanning microscope (Zeiss LSM 410, Germany) upon excitation at 405 nm. The 
images were analyzed using Image-Pro Plus 5.0 software to obtain the corresponding 
green and red fluorescence intensity for each SKBR-3 and HT-29 cell on average (n = 
200), respectively. The same procedures were carried out for labeling SKBR-3 cells by 
APFVBTNPs and labeling HT-29 cells by RPFVNPs. 
5.2.11 Discrimination of Live Target Cells in Cell Mixtures 
SKBR-3 and HT-29 cells were treated with 1× trypsin and washed with 1× PBS 
through centrifugation. Approximately 5 × 105 of each type of the cells were mixed 
and dispersed in 1 mL of 1× PBS (5 mM MgCl2). APFVNP (175 μL, 0.5 mg/mL) was 
added into the cell mixture, followed by the addition of RPFVBTNP (175 μL, 0.5 
mg/mL). After incubation for 10 min, the cells were washed with 1× PBS (5 mM 
MgCl2) through centrifugation at 1,500 rpm and finally suspended in 0.5 mL of 1× 
PBS. For confocal imaging, cell suspension was dropped on a glass slide and imaged 
immediately by confocal laser scanning microscope (Zeiss LSM 410, Germany) upon 
excitation at 405 nm and the fluorescence signals for APFVNPs and RPFVBTNPs 
were collected simultaneously using a band pass 480-495 nm filter and 620 nm 
longpass barrier filter. The images were analyzed using Image-Pro Plus 5.0 software to 
obtain the total fluorescence intensity of green signal for SKBR-3 cells and that of red 
signal for HT-29 cells in the mixture, respectively. The number of SKBR-3 cells and 
HT-29 cells in mixture was further calculated to obtain the ratio of two cell lines. The 
discrimination of cell mixture using APFVBTNPs and RPFVNPs was also carried out 
following the same procedure. 
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5.3 Results and Discussion 
5.3.1 Synthesis and Characterization of PFV and PFVBT 
The PFV was synthesized according to literature.30 For PFVBT, 1, 2 and 
4,7-dibromo-2,1,3-benzothiadiazole were copolymerized via Pd(OAc)2/P(o-tolyl)3 
catalyzed Heck coupling reaction in a mixture of dimethylformamide/triethylamine (2 : 
1) for 2 h at 100 °C under argon to afford PFVBT in 58% yield after purification 
(Scheme 5.1). Comparison between the integrated areas for the multiple peaks at 
7.71-7.27 ppm (the aryl and vinyl protons) to that at 2.51 ppm (the alkyl protons next 
to the 9-position of fluorene) in the 1H NMR spectrum of PFVBT reveals that the 
content of BT units in the polymer is ~9.5 mol%. The PFV and PFVBT have number 
average molecular weights and polydispersities of 10500 (1.9) and 9600 (2.0), 
respectively, determined by gel permeation chromatography (GPC) using 
tetrahydrofuran as the solvent and polystyrene as the standard. 
 
Scheme 5.1 Synthetic entry to PFVBT. 
 
The UV-vis absorption and PL spectra of PFV and PFVBT in solid films are shown in 
Figure 5.1. The absorption maxima for PFV and PFVBT films are 435 and 437 nm, 
respectively. A weak absorption band ranging from 490 to 560 nm is also observed for 
PFVBT, which corresponds to the BT units. The emission maxima for PFV and 
PFVBT films are 481 and 620 nm, respectively. The significantly red-shifted emission 
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fluorenylvinylene moieties to BT units in aggregation. The PL quantum yields (Φ) for 
PFV and PFVBT films are 0.12 and 0.21, respectively, measured using quinine sulfate 
in 0.1 M H2SO4 as the standard. As compared to the low fluorescence quantum yields 
for most green and red emission polymers used for nanoparticle formation,41-42 PFV 
and PFVBT are ideal for fabrication of CP NPs.  



























Wavelength (nm)  
Figure 5.1 UV-vis absorption and PL spectra of PFV (black) and PFVBT (red) in films 
(λex = 405 nm). 
 
5.3.2 Synthesis and Functionalization of CP NPs  
The nanoparticles for PFV (PFVNPs) and PFVBT (PFVBTNPs) were synthesized via 
a modified solvent extraction/evaporation single emulsion method using PLGA-COOH 
as the encapsulation matrix.28 Laser light scattering study reveals that the PFVNPs and 
PFVBTNPs have volume average hydrodynamic diameters of 185 ± 5 and 191 ± 6 nm, 
respectively. According to previous reports, polymeric nanoparticles within 200 nm 
size range have shown great potentials for both in vitro and in vivo applications.43-45 
The zeta potentials for PFVNPs and PFVBTNPs are -41.3 ± 2.3 mV and -43.7 ± 2.7 
mV, respectively, which are attributed to the presence of excessive carboxyl groups on 
the surface. The encapsulation efficiencies of PFV and PFVBT for PFVNPs and 
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PFVBTNPs are 51% and 48%, respectively, by comparing the fluorescence intensity of 
freeze-dried NPs dissolved in DCM against the corresponding standard curves.  
 
Scheme 5.2 Schematic illustration of the fabrication of anti-HER2 affibody and RGD 
peptide functionalized CP loaded NPs. 
 
The PFVNPs and PFVBTNPs were functionalized with anti-HER2 affibody through 
EDAC mediated coupling reaction between -COOH groups on NP surface and -NH2 
groups of affibody to yield affibody conjugated PFVNPs/PFVBTNPs 
(APFVNPs/APFVBTNPs). In addition, both PFVBTNPs and PFVNPs were treated 
with positively charged RGDKKKKKK peptide (isoelectric point pI ≈ 11.2) through 
electrostatic interaction in 0.1× PBS buffer (pH = 7.4), yielding RGD peptide modified 
RPFVBTNPs/RPFVNPs. The schematic illustration of surface functionalized 
PFVNPs/PFVBTNPs is shown in Scheme 5.2. The numbers of affibody and RGD 
peptide immobilized on each NP surface were subsequently quantified via Bradford 
protein assay and fluorescamine assay, respectively.46-47 To avoid the absorbance and 
fluorescence interference from the encapsulated CPs on surface protein or peptide 
quantification, bare NPs (without encapsulating CPs) with a similar size to that of 
PFVNPs/PFVBTNPs were prepared and modified with the affibody or RGD peptide 
following the same surface functionalization procedure. The numbers of affibody or 
RGD peptide immobilized on each NP were estimated to be ∼3400 ± 100 and ∼7500 ± 
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100, respectively.  
5.3.3 Characterization of Surface Functionalized CP NPs  
 
Figure 5.2 TEM images of APFVNPs (A) and RPFVBTNPs (B). 
 
Figure 5.2 shows the morphology of APFVNPs and RPFVBTNPs investigated with 
TEM. The high electron density of CP molecules ensures clear visualization of 
spherical CP NPs. APFVNPs and RPFVBTNPs have the particle sizes of 189 ± 6 and 
193 ± 4 nm, respectively, which are only slightly larger than those of PFVNPs and 
PFVBTNPs. However, the surface functionalization leads to obvious decreases in zeta 
potentials from -41.3 ± 2.3 for PFVNPs to -24.5 ± 2.1 mV for APFVNPs, and from 
-43.7 ± 2.7 mV for PFVBTNPs to -15.5 ± 1.3 mV for RPFVBTNPs, respectively. The 
successful surface functionalization is further confirmed by XPS. The typical peak at 
~397.5 eV of nitrogen (N 1s) can be clearly observed in the XPS spectra of APFVNPs 
and RPFVBTNPs (Figure 5.3), indicating the presence of affibody and RGD peptide 
on surface as there is no nitrogen element in PFVNPs and PFVBTNPs (Figure 5.3B), 
respectively. Similar results were also obtained for APFVBTNPs and RPFVNPs. 
A                                                                 B




Figure 5.3 The XPS wide scan spectra of (A) the APFVNPs (black) and RPFVBTNPs 
(red), (B) the PFVNPs (black) and PFVBTNPs (red). The insets show the relative 
nitrogen signals at high resolution. 
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Figure 5.4 UV-vis absorption and PL spectra of APFVNP and RPFVBTNP 
suspensions in water at [NP] = 2 mg/mL (λex = 405 nm). The inset shows the 
photographs of corresponding suspensions under UV excitation at 365 nm. 
 
As shown in Figure 5.4, the UV-vis absorption and PL spectra of APFVNP and 
RPFVBTNP in aqueous suspensions are 434 and 436 nm, respectively, with shoulders 
at around 405 nm, which effectively matches the 405 nm laser excitation. The emission 
maximum for APFVNPs is 483 nm, which is significantly red-shifted to 622 nm for 
RPFVBTNPs. These emission maxima perfectly match the signal collection using a 
band pass 480-495 nm filter for green fluorescence channel (APFVNP) and a 620 nm 
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long pass barrier filter for red fluorescence channel (RPFVBTNP). It is also important 
to note that the overlap between the two emission spectra in the signal collection range 
is very small. Considering APFVNPs (Φ = 0.11) and RPFVBTNPs (Φ = 0.19) also 
have good PL quantum yields in water, the surface functionalized nanoparticles are 
ideal for multiple cancer cell detection using confocal laser scanning microscopy upon 
excitation at 405 nm with dual channel signal collection.  
5.3.4 Targeting Ability of Surface Functionalized CP NPs for Cancer Cell 
Detection  
SKBR-3 breast cancer cells and HT-29 colon cancer cells that have over-expressed 
HER2 and integrin receptors were used as the target cells.48-49 The detection of 
SKBR-3 cancer cells and HT-29 cancer cells was demonstrated by staining HER2 and 
integrin receptors in cell membrane of live cells in aqueous suspension at 4 °C. 
Previous studies indicate that fluorescent probes could specifically stain the cell 
membrane without internalization at 4 °C.50 
The targeting ability and fluorescence signal interference of APFVNPs and 
RPFVBTNPs were first investigated upon excitation with a 405 nm laser. Figure 5.5 
shows the confocal images of pure live SKBR-3 cell or HT-29 cell suspensions treated 
with 65 µg/mL APFVNPs and RPFVBTNPs, respectively, for 10 mins at 4 °C. For 
each sample, the fluorescence signals were collected with a 480-495 nm filter and a 
620 nm long pass barrier filter under the same confocal setup. The bright green 
fluorescence in Figure 5.5A indicates that SKBR-3 cell is successfully stained by 
APFVNPs, while the negligible fluorescence from Figure 5.5B indicates that there is 
almost no interference signal at above 620 nm. On the other hand, RPFVBTNPs 
labeled HT-29 cells show obvious red fluorescence signal at above 620 nm (Figure 
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5.5F) and the fluorescence signal in the range of 480-495 nm remains extremely low 
(Figure 5.5E). The 3D confocal fluorescence images for APFVNP treated SKBR-3 
cells and RPFVBTNP treated HT-29 cells were also obtained (Figures 4.5D and 4.5H), 
which indicate that the green and red fluorescence are from the cell surface. These 
results suggest that SKBR-3 and HT-29 cancer cell membranes are effectively stained 
by APFVNPs and RPFVBTNPs, respectively. Similar results were obtained when 
APFVBTNPs and RPFVNPs were used for SKBR-3 and HT-29 cancer cell stain as 
shown in Figure 5.6. As a control, confocal images were taken for both cancer cells 
after incubation with PFVNPs or PFVBTNPs under the same experimental conditions, 
which indicate that non-specific interactions between unmodified CP NPs and the cell 
membrane are negligible (Figure 5.7). As such, the as-prepared 
APFVNPs/RPFVBTNPs or APFVBTNPs/RPFVNPs should be suitable for 
simultaneous detection of SKBR-3 and HT-29 cancer cells in one solution. 
 
Figure 5.5 Confocal images and fluorescence/transmission overlapped images of 
suspended live SKBR-3 cells (A, B, C) and HT-29 cells (E, F, G) stained with 
APFVNPs and RPFVBTNPs (65 µg/mL) for 10 min at 4 °C, respectively. 3D sectional 
confocal images of corresponding SKBR-3 cells (D) and HT-29 cells (H). The scale 
bars of images A-C and E-G are the same while images D and H share the same scale 
bare. 
 





Figure 5.6 Confocal images and fluorescence/transmission overlapped images of 
suspended live SKBR-3 cells (A, B, C) and HT-29 cells (D, E, F) stained with 
APFVBTNPs and RPFVNPs (65 µg/mL) for 10 min at 4 °C, respectively. The scale 
bars of images A-F are the same. 
 
 
Figure 5.7 Confocal images of (A) SKBR-3 and (C) HT-29 cell suspensions after 
staining with PFVNPs and PFVBTNPs (65 µg/mL) for 10 min at 4 °C, respectively. (B) 
and (D) are the corresponding fluorescence/transmission overlapped images. The scale 
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RPFVNPs were also successfully demonstrated in mixed cancer cell detection. In this 
case, SKBR-3 cells and HT-29 cells could be easily distinguished from red and green 
fluorescence, respectively Figure 5.9. These results demonstrate that 
APFVNP/RPFVBTNP or APFVBTNP/RPFVNP could serve as specific dual color 
fluorescent probes for mixed live HER2 and integrin receptor positive cancer cell 
discrimination under single laser excitation. 
























Figure 5.10 Metabolic viability of NIH/3T3 fibroblast cells after incubation with 
PFVNP and PFVBTNP suspensions at concentrations of 900, 1800 and 3600 μg/mL 
for 48 h, respectively. 
 
As a critical issue in living cell imaging, the cytotoxicity of PFVNPs and PFVBTNPs 
was evaluated by metabolic viability of NIH/3T3 fibroblast cells after incubation with 
these nanoparticles. The cell metabolic viability after incubation with PFVNPs and 
PFVBTNPs at concentrations of 900, 1800 and 3600 µg/mL for 48 h is shown in 
Figure 5.10. The metabolic viability of NIH/3T3 cells remains above 95% after 
incubation with both NP suspensions under the studied conditions, indicating low 
cytotoxicity of PFVNPs and PFVBTNPs. It is noteworthy that the maximum NP 
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concentration in cytotoxicity study is ~60 times higher than that used for imaging 
experiments. These results suggest that PFVNPs and PFVBTNPs are promising 
fluorescent platforms for live cell imaging applications. 
5.4 Conclusion 
In summary, PFVNPs and PFVBTNPs with surface anti-HER2 affibody and RGD 
peptide functionalization were synthesized for simultaneous detection of HER2 
positive and integrin receptor positive cancer cells in mixed cell suspension under 
single laser excitation. The CP NPs were fabricated through a solvent 
extraction/evaporation single emulsion method using poly(lactic-co-glycolic-acid) as 
the encapsulation matrix that facilitates further surface modification. By introducing a 
small percentage of BT units as the low-energy trap into PFV backbone, the obtained 
PFVBTNPs show similar absorption maximum but dramatically red-shifted emission 
maximum relative to PFVNPs due to aggregation enhanced energy transfer upon NP 
formation. The minimal emission spectral overlap between APFVNPs and 
RPFVBTNPs satisfies non-interfering dual channel signal collection, which ensures 
clear discrimination between SKBR-3 and HT-29 cancer cells in solution. As compared 
to other fluorescent probes for multiplexing, the single polymer loaded multicolor 
nanoparticles have advantages of low cytotoxicity, easy preparation and good 
reproducibility. With the development of more specific targeting probes and 
customized conjugated polymers, the conjugated polymer loaded nanoparticles with 
good photostability and fine-tuned optical properties could become a new class of 
powerful fluorescent probes for multiple biological targets detection upon single laser 
excitation.  
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Besides cellular imaging, imaging and tracking cytoplasmic proteins in living cells 
through feasible and efficient fluorescent techniques remains a vital challenge in 
biological and biomedical research.1-3 As an important protein in all eukaryotic cells, 
actin is implicated in a number of cellular activities, which include shape 
determination, cytokinesis, and cell motility.4-5 Labeling actin in living cells offers 
great potentials for understanding the dynamics of various intracellular processes.6-14 
However, to achieve living cell imaging of actin, sophisticated techniques (e.g., 
microinjection, electroporation and permeabilization) or nanocarriers (e.g., liposomes) 
are required to deliver organic fluorophore or QD conjugates into living cells due to 
inefficient living cell membrane permeability of these fluorescent species.6-14 An 
alternative strategy relies on green fluorescent protein (GFP)-actin fusion proteins 
which can be integrated into actin filaments after delicate transfection.15-16 These 
processes generally require multiple steps, which increase the imaging complexity and 
may alter the state of cells. In addition, intrinsic disadvantages of these fluorescent 
probes, such as poor photostability for organic fluorophores and GFP, and cytotoxicity 
for QDs, greatly restrict their applications in imaging living biosubstrates.17 The 
development of novel fluorescent materials with high cellular internalization efficiency, 
good photostability and high specificity for actin cytoskeleton staining is in urgent 
demand. 
Conjugated polyelectrolytes (CPEs) are water-soluble conjugated polymers with 
highly delocalized backbone structures.18-19 As compared to their small molecule 
counterparts, CPEs have larger absorption cross sections and higher brightness.20-22 
Due to their good photostability and low cytotoxicity, there is increasing interest in 
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using CPEs as nonspecific fluorescent probes for cellular imaging.23-29 Although 
CPE-based selective recognition of extracellular matrix protein through nonspecific 
polyvalent interaction has been demonstrated,24 subcellular protein targeting in living 
cells with specific CPEs remains a challenge. To achieve living cell intracellular 
protein detection, the CPE has to be designed with efficient intracellular delivery and 
specific targeting capability.30-33 Motivated by the fact that three-dimensional 
dendrimers or nanoparticles with sizes of 20-50 nm could be efficiently internalized by 
living cells,34-39 we look for conjugated polymers born with surface functional groups 
and three dimensional structures. It occurs to us that hyperbranched conjugated 
polymers have been reported to show tunable optical properties, three dimensional 
structures with flexible surface functionalization.26,40-42 In addition, due to their 
intrinsic fluorescence, these polymers are significantly different from traditional 
dendrimers, which rely on dye conjugation to yield fluorescence and share the 
drawback of dye molecules, such as photobleaching and low brightness.43 As such, 
water-soluble hyperbranched CPEs could serve as a potential platform for construction 
of fluorescent probes for targeted biosubstrate imaging in living cells.  
In this contribution, we report that the phalloidin-functionalized hyperbranched 
conjugated polyelectrolyte (HCPE-phalloidin) is suitable for direct filamentous actin 
(F-actin) imaging in living Hela cells. The molecular design is based on a cationic 
HCPE core and a PEG out layer to ensure its biocompatibility and weak nonspecific 
interaction with biomolecules. Commercially available phalloidin, a cyclic peptide, is 
chosen as the targeting moiety because of its high affinity to F-actin cytoskeleton.44-45 
The human epithelial carcinoma cell line, Hela cell, is used in this study because it is 
one of the most commonly used cancer cell lines for F-actin imaging.14,46-50 The 
performance of HCPE-phalloidin in living cell F-actin imaging has been evaluated, 
                                                                       Chapter 6 
113 
 
which is superior to commercially available fluorescent phalloidin conjugates in terms 
of imaging simplicity, living cell internalization and photostability. 
6.2 Experimental Section 
6.2.1 Materials 
Amino-phalloidin (phalloidin amino-, tosylate) was purchased from Enzo Life 
Sciences. MTT, sucrose, genistein, EDAC, Sulfo-NHS, THF, DMF, trimethylamine 
(TMA), and penicillin-streptomycin solution were purchased from Sigma-Aldrich. 
FBS, trypsin-EDTA solution, and Alexa Fluor ® 488-phalloidin were purchased from 
Invitrogen (Life Technologies). 10× PBS buffer with pH = 7.4 (ultrapure grade) was a 
commercial product of 1st BASE Singapore. Milli-Q water was supplied by Milli-Q 
Plus System (Millipore Corporation, Breford, USA). DMEM medium was purchased 
from National University Medical Institutes (NUMI, Singapore). Hela cells were 
provided by American Type Culture Collection. 
6.2.2 Characterization  
NMR spectra were collected on Bruker Avance 500 (DRX 500, 500 MHz). UV-vis 
spectra were recorded on a Shimadzu UV-1700 spectrometer. The fluorescence spectra 
were measured using a Perkin Elmer LS-55 equipped with a xenon lamp excitation 
source and a Hamamatsu (Japan) 928 PMT, using 90 degree angle detection for 
solution samples. High-resolution transmission electron microscopy (HR-TEM) 
images were obtained from a JEOL JEM-2010 transmission electron microscope with 
an accelerating voltage of 200 kV. Average particle size was determined by laser light 
scattering (LLS) with particle size analyzer (90 Plus, Brookhaven Instruments Co. 
USA) at a fixed angle of 90° at room temperature. 
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6.2.3 Cell Cultures  
Hela cells were cultured (37 °C, 5% CO2) in Dulbecco's Modified Eagle Medium 
(DMEM) medium containing 10% fetal bovine serum and 1% penicillin streptomycin. 
Before experiment, the cells were pre-cultured until confluence was reached. 
6.2.4 Synthesis of P0  
A Schlenk tube charged with 
4-(9,9'-bis(6-bromohexyl)-7-ethynylfluorenyl)-7-ethynylbenzothiadiazole (100 mg, 
0.15 mmol) was degassed with three vacuum-nitrogen cycles. A solution of 
cyclopentadienylcobaltdicarbonyl (CpCo(CO)2) in anhydrous toluene (1.5 mL, 0.01 M) 
was then added to the tube, and the system was further frozen, evacuated, and thawed 
three times to remove oxygen. The mixture was vigorously stirred at 65 °C under 
irradiation with a 200 W Hg lamp (operating at 100 V) placed close to the tube for 8 h. 
After the mixture was cooled to room temperature, it was dropped into methanol (100 
mL) through a cotton filter. The precipitate was collected and re-dissolved in THF. 
The resultant solution was filtered through 0.22 μm filter, and poured into hexane to 
precipitate the product. After drying in vacuum at 40 °C, the neutral hyperbranched 
polymer precursor (P0) was obtained as light brown powders (65 mg, 65%).  1H NMR 
(500 MHz, CDCl3, δ ppm): 8.50-7.20 (m, 9 H), 3.67 (s, ~0.6 H), 3.30 (br, 4 H), 2.0 (br, 
4 H), 1.70 (br, 4 H), 1.42-1.06 (m, 8 H), 0.77 (br, 4 H). 13C NMR (125 MHz, CDCl3, δ 
ppm): 155.41, 154.34, 153.73, 153.06, 151.10, 150.97, 150.91, 150.08, 141.43, 140.50, 
137.87, 134.02, 131.45, 129.04, 128.53, 128.23, 126.54, 125.30, 123.97, 120.68, 
120.30, 119.98, 84.60, 83.30, 80.88, 77.92, 55.27, 40.10, 33.91, 32.64, 29.06, 27.77, 
23.65. 
6.2.5 Synthesis of P1 
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P0 (50 mg) was dissolved in THF (10 mL), and TMA (2 mL) was added dropwise to 
the solution at −78 °C. The mixture was stirred for 12 h, and then allowed to warm to 
room temperature. The precipitate was redissolved by the addition of methanol (8 mL). 
After the mixture was cooled to −78 °C, additional TMA (2 mL) was added, and the 
mixture was stirred at room temperature for 24 h. After solvent removal, acetone was 
added to precipitate P1 as light brown powders (55 mg, 95%). 1H NMR (500 MHz, 
CD3OD, δ ppm): 8.77-7.35 (m, 9 H), 3.63 (s, ~0.6 H), 3.28 (br, 4 H), 3.05 (s, 18 H), 
2.05 (br, 4 H), 1.58 (br, 4 H), 1.20 (br, 8 H), 0.77 (br, 4 H). 
6.2.6 Synthesis of HCPE-COOH  
P1 (15 mg, 0.008 mmoL) and N3-PEG-COOH (71 mg, 0.125 mmoL) were dissolved 
in DMF (5 mL). The mixture was degassed, and then 
N,N,N',N",N"-pentamethyldiethylenetriamine (PMDETA, 6 mg, 0.04125 mmoL) and 
CuBr (5.9 mg, 0.04125 mmoL) were added. After reaction at 65 °C under nitrogen for 
24 h, the mixture was cooled to room temperature and filtered through 0.22 μm syringe 
driven filter. The filtrate was precipitated into diethyl ether. The crude product was 
redissolved in water and further purified by dialysis against Milli-Q water using a 3.5 
kDa molecular weight cutoff dialysis membrane for 5 days. After freeze-drying, 
HCPE-COOH (16 mg, 77%) was obtained as brown fibers. 1H NMR (500 MHz, 
CD3OD, δ ppm): 8.55-7.88 (m, ~9.6 H), 4.00-3.37 (m, ~23.0 H), 3.17-3.00 (m, 22 H), 
2.28 (m, 4 H), 1.60 (br, 4H), 1.5-1.20 (m, 8 H), 0.9 (m, 4 H). 
6.2.7 Synthesis of HCPE-phalloidin 
The conjugation of HCPE-COOH with amino-phalloidin was carried out through 
EDAC coupling reaction. In brief, 0.22 mL of HCPE-COOH (18 mg/mL) aqueous 
solution and 0.76 mL of amino-phalloidin (1 mg/mL, methanol) were mixed and 
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diluted to a total volume of 4 mL in borate buffer (0.2 M, PH = 8.5). EDAC and 
Sulfo-NHS were then added into the solution at a stoichiometric molar ratio of 
HCPE-COOH/EDAC/Sulfo-NHS = 1/5/5. The reaction was allowed to carry on for 3 h 
at room temperature with gentle mixing. The obtained product was dialyzed using a 
500 Da molecular weight cutoff dialysis membrane against MilliQ water for 1 day to 
eliminate the excess EDAC and Sulfo-NHS. The solution was further dialyzed using a 
3.5 kDa molecular weight cutoff dialysis membrane for 2 days to eliminate the free 
amino-phalloidin, and the Milli-Q water after each run of dialysis was collected and 
concentrated for HPLC analysis. HCPE-phalloidin was finally collected after 
freeze-drying.  
6.2.8 Cellular Uptake Study of HCPE-Phalloidin and HCPE-COOH  
Hela cells (2 × 104 cells/mL) were seeded into 96-well black plates (Costar, IL, USA) 
and incubated for 48 h to evaluate the cellular uptake processes. Four groups of cells 
were incubated with HCPE-phalloidin in FBS-free DMEM for 2 h at  37 °C (A), 4 °C 
(B), 37 °C with pretreatment of sucrose (C), and 37 °C with pretreatment of genistein 
(D), respectively. Six wells were used for each group. The cells incubated with 
HCPE-phalloidin at 37 °C without inhibitor pretreatment (A) was used as the control. 
To study the effect of incubation temperature on cellular uptake, the cells were 
incubated with 1 µg/mL HCPE-phalloidin nanosphere solution for 2 h at 4 °C (B). To 
study the effect of different inhibitors on specific endocytosis processes, fresh 
FBS-free DMEM medium supplemented with 4% w/v sucrose (C) or 0.2 mM genistein 
(D) were added into each sample well and the cells were pre-incubated for 1 h at 37 °C. 
The medium was then removed and HCPE-phalloidin in FBS-free DMEM (1 µg/mL) 
was subsequently added into each sample well and incubated for 2 h at 37 °C. After 
incubation, the control (A) and sample wells (B, C, D) were washed twice with 50 µL 
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1× PBS buffer to remove traces of nanospheres. DMEM medium (100 μL, FBS free) 
was then added to each well, which was followed by addition of 50 µL of 0.5% Triton 
X-100 in 0.2 N NaOH to lyse the cells. The fluorescence intensity of HCPE-phalloidin 
nanospheres at 586 nm in each well was then measured by microplate reader (Genios 
Tecan) with excitation wavelength of 405 nm. The relative cellular uptake efficiency 
under different conditions was expressed as the ratio of the fluorescence in the 
corresponding sample wells to that of the control wells. The study of cellular uptake of 
HCPE-COOH was carried out following the same procedures. 
6.2.9 Cytotoxicity of HCPE-COOH 
MTT assays were performed to assess the metabolic activity of Hela cells. Cells were 
seeded in 96-well plates (Costar, IL, USA) at an intensity of 2 × 104 cells/mL. After 48 
h incubation, the old medium was replaced by the HCPE-COOH solution in medium at 
different HCPE-COOH concentrations, and the cells were then incubated for 12, 24 
and 48 h, respectively. After the designated time intervals, the wells were washed twice 
with 1× PBS buffer and 100 µL of freshly prepared MTT (0.5 mg/mL) solution in 
culture medium was added into each well. The MTT medium solution was carefully 
removed after 3 h incubation in the incubator. DMSO (100 µL) was then added into 
each well and the plate was gently shaken for 10 minutes at room temperature to 
dissolve all the precipitates formed. The absorbance of MTT at 570 nm was monitored 
by the microplate reader. Cell viability was expressed by the ratio of absorbance of the 
cells incubated with nanosphere solution to that of the cells incubated with culture 
medium only.  
6.2.10 F-Actin Labeling in Living Hela Cells  
Hela cells were cultured in the confocal imaging chamber (LAB-TEK, Chambered 
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Coverglass System) at 37 °C. After 80% confluence, the medium was removed and the 
adherent cells were washed twice with 1× PBS buffer. The HCPE-phalloidin in FBS 
free DMEM medium (1 µg/mL) was then added to the chambers. After incubation for 
2 h, the cells were washed three times with 1× PBS buffer to eliminate the excess 
HCPE-phalloidin and imaged by confocal laser scanning microscope (CLSM, Zeiss 
LSM 410, Jena, Germany) with imaging software (Fluoview FV1000). HCPE-COOH 
for living cell imaging was also carried out following the same procedure. Hela cells 
cultured with Alexa Fluor ® 488-phalloidin in DMEM medium (0.1 µM, FBS free) for 
2 h were also imaged. 
6.2.11 F-Actin Labeling in Fixed and Permeabilized Hela Cells  
Hela cells were cultured in the confocal imaging chamber (LAB-TEK, Chambered 
Coverglass System) at 37 °C. After 80% confluence, the medium was removed and the 
adherent cells were washed twice with 1× PBS buffer. The cells were fixed with 3.7% 
paraformaldehyde for 10 min at 37 °C and permeabilized with 0.1% triton X-100 for 5 
min at room temperature. The fixed and permeabilized cells were further blocked by 1% 
BSA in 1× PBS buffer for 30 min and washed three times with 1× PBS buffer. The 
cells were then incubated with Alexa Fluor ® 488-phalloidin in 1× PBS buffer for 30 
min at room temperature, respectively. After washing with 1× PBS buffer, imaging was 
carried out on confocal laser scanning microscope (CLSM, Zeiss LSM 410, Jena, 
Germany) with imaging software (Fluoview FV1000). 
6.2.12 Photostability Studies  
The confocal samples of Hela cells incubated with HCPE-phalloidin or stained with 
Alexa Fluor ® 488-phalloidin were prepared according to previously described 
procedures. The confocal images of each sample were recorded at 1 min interval under 
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continuous laser scanning at excitation wavelength of 405 nm or 488 nm for 
HCPE-phalloidin and 488 nm for Alexa Fluor ® 488-phalloidin (1 mW for 405 nm 
laser and 1.25 mW for 488 nm laser). The fluorescence intensity of each image was 
analyzed by ImageJ software. The photostability of HCPE-phalloidin and Alexa Fluor 
® 488-phalloidin was expressed by the ratio of fluorescence intensity of each sample 
after excitation for a designated time interval to its initial value as a function of 
exposure time. 
6.3 Results and Discussion 
6.3.1 Synthesis and Characterization of HCPE-phalloidin 
The neutral hyperbranched conjugated polymer (P0) was synthesized by alkyne 
polycyclotrimerization,51 from 
4-(9,9'-bis(6-bromohexyl)-7-ethynylfluorenyl)-7-ethynylbenzothiadiazole in 65% yield. 
From the 1H NMR spectrum of P0 as shown in Figure 6.1A, the ratio of the integrated 
area for the peak at 3.67 ppm (the proton resonance of residual alkynes) to that at 2.00 
ppm (the proton resonance of methylene groups next to the 9-position of fluorene) is 
~0.14, which indicates that the percentage of triple bond involved in new benzene 
formation is 72%. According to the equations reported by Tang et. al,51 the number of 
newly formed benzene ring is estimated to be 12, and the degree of polymerization is 
25, which yields the number average molecular weight of P0 as ~16000. Therefore, 
there are ~14 residual alkynes for further functionalization. These calculations are 
based on the assumption that there is no or low amount of loops formed during 
polymerization, which is reasonable considering the steric effect of the monomer and 
mathematical probabilities. 




Figure 6.1 1H NMR spectra of (A) P0 and (B) HCPE-COOH. The solvent peak at 7.29 
ppm corresponds to the chemical shift of chloroform-d (A), and peaks at 4.85 ppm and 
3.33 ppm correspond to chemical shifts of H2O and methanol-d (B). 
 
Subsequent treatment of P0 with TMA in THF/methanol yielded water-soluble P1 in 
95% yield. The attachment of N3-PEG-COOH to P1 was achieved through click 
reaction, which was carried out at 65 °C for 24 h under nitrogen in DMF using 
PMDETA and CuBr as the catalyst. The obtained HCPE-COOH was purified by 
microfiltration and precipitation, which was followed by dialysis against Milli-Q water 
for 5 days and freeze drying. From the 1H NMR spectrum of HCPE-COOH as shown 
in Figure 6.1B, the ratio of the integrated area for the peak at 8.55 ppm (the proton 
next to the nitrogen atom of the triazole group) to that at 2.28 ppm (the proton 
resonance of methylene groups next to the 9-position of fluorene) is ~0.14, which 
suggests that almost all the residual alkynes are converted to triazole groups to yield 
~14 PEG-COOH/P1. The number average molecular weight of HCPE-COOH is thus 
estimated to be ~26000.  The HCPE-COOH was subsequently functionalized with 
amino-phalloidin through EDAC mediated coupling reaction in the presence of 
Sulfo-NHS at room temperature for 3 h. The final conjugate (HCPE-phalloidin) was 
purified by dialysis against Milli-Q water for 3 days, followed by freeze-drying. The 
synthetic entry to HCPE-phalloidin is shown in Scheme 6.1. 












Scheme 6.1 The synthetic entry to HCPE-phalloidin. Conditions and reagents: (i) 
toluene, CpCo(CO)2, 65 °C, 8 h; (ii) THF/methanol, TMA, 24 h; (iii) DMF, 
PMDETA/CuBr, 65 °C, 24 h; (iv) borate buffer, EDAC/sulfo-NHS, RT, 3 h.  
 
HR-TEM was employed to study the morphology of the HCPE-phalloidin in solid state. 
As shown in Figure 6.2A, HCPE-phalloidin forms spherical nanospheres with a 
core-shell structure, which consists of a dark interior (electron-rich conjugated 
segments) and a gray exterior (saturated PEG segments and phalloidin). Statistical 
calculation from HR-TEM images indicates that the average diameter of 
HCPE-phalloidin is 26 ± 2 nm, which is slightly smaller than that determined from 
LLS with an average hydrodiameter of 32 ± 3.0 nm in aqueous solution, due to 
shrinkage of the polymeric nanospheres during drying process.26 The hydrodiameter of 
HCPE-COOH is also measured to be 32 ± 3.5 nm, suggesting that conjugation of 
phalloidin molecule has negligible effect on the nanosphere size. Figure 6.2B shows 
the UV-vis absorption and PL spectra of HCPE-phalloidin in water. The absorption 
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586 nm, which match the confocal laser scanning microscope with 405 nm excitation 
and 520 nm longpass barrier filter for signal collection.  
 
Figure 6.2 (A) High-resolution TEM image of HCPE-phalloidin nanospheres. (B) 
UV-vis absorption and PL spectra of HCPE-phalloidin in water (λex = 419 nm). 
 
6.3.2 F-actin Imaging in Living Hela Cells 
The ability of HCPE-phalloidin nanospheres to label F-actin in living Hela cells was 
investigated by confocal laser scanning microscopy, and the corresponding images are 
shown in Figure 6.3. The experimental conditions are set so that no autofluorescence 
from cells is detectable. Under the same laser and filter setup, the confocal and 
fluorescence/transmission overlapped images of Hela cells after incubation with 1 
µg/mL of HCPE-phalloidin for 2 h at 37 °C were obtained and illustrated in Figures 
5.3A and 5.3B, respectively. The images were taken by focusing on the bottom layer of 
cells to monitor F-actin distribution. It is obvious that the cell periphery is brighter 
than other region of the cells, which is similar to that for fixed and permeabilized Hela 
cells stained with commercial Alexa Fluor ® 488-phalloidin (Figures 5.3D and 5.3E). 
This result indicates specific interaction between HCPE-phalloidin and F-actin, which 
is concentrated more along the cell periphery than in the cytoplasm of Hela cells.46-50 
The 3D sectional confocal image of the corresponding cells in Figure 6.3C further 
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confirms that the HCPE-phalloidin nanospheres are internalized into living Hela cells 
to label F-actin underneath the cell membrane.52-53  
 
Figure 6.3 Confocal image (A), fluorescence/transmission overlapped image (B) and 
3D sectional confocal image (C) of the Hela cells after incubation with 1 µg/mL 
HCPE-phalloidin in culture medium for 2 h at 37 °C (λex = 405 nm, 1 mW laser power). 
Confocal image (D) and fluorescence/transmission overlapped image (E) of the fixed 
and permeabilized Hela cells stained by Alexa Fluor ® 488-phalloidin (λex = 488 nm, 
1.25 mW laser power). Confocal image (F) of the Hela cells after incubation with 1 
µg/mL HCPE-COOH for 2 h at 37 °C (λex = 405 nm, 1 mW laser power). 
 
The confocal image shown in Figure 6.3A also indicates that the HCPE-phalloidin 
nanospheres have better performance in living cell actin imaging as compared to that 
for various nanocarrier promoted QD and organic fluorophore based phalloidin 
conjugates.10,13,14,31 It is important to note that Alexa Fluor ® 488-phalloidin is not able 
to clearly label F-actin upon direct incubation with living Hela cells as organic 
chromophore phalloidin conjugates have low living cell membrane permeability 
(Figure 6.4).6-10 In addition, when HCPE-COOH is used for direct incubation with 
living Hela cells, the nanospheres are found to uniformly distributed in cell cytoplasm 
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of phalloidin molecules does not alter the internalization pathway of the HCPE 
nanospheres into Hela cells. Moreover, the metabolic viability of Hela cells remains 
above 94% after culture with 0.1 mg/mL HCPE-COOH for 48 h, indicating very low 
cytotoxicity of the nanospheres (Figure 6.5). Considering their good living cell 
permeability and low cytotoxicity, various functionalized HCPE nanospheres with 



















HCPE-COOH (mg/mL)  
Figure 6.5 Metabolic viability of Hela cells treated with the HCPE-COOH solutions at 
the concentrations of 0.025, 0.05, and 0.1 mg/mL for 12 h (blank), 24 h (gray), and 48 
h (dark gray), respectively. 
 
6.3.4 Photostability Study 
The photostability of the HCPE-phalloidin in Hela cells was also studied under 
continuous laser scanning upon excitation at 405 nm and 488 nm for HCPE-phalloidin 
and 488 nm for Alexa Fluor ® 488-phalloidin, respectively. As shown in Figure 6.6, 
HCPE-phalloidin shows ~6% and ~11% decrease of fluorescence intensity under 
continuous laser excitation at 488 nm and 405 nm for 10 min, respectively, which is 
obviously less as compared to that for Alexa Fluor ® 488-phalloidin under the same 
condition. As Alexa Fluor is well-known for its high photostability,6 this study 
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indicates that HCPE-phalloidin is a promising fluorescent probe for long-term F-actin 
imaging in living cells. 














Figure 6.6 Photostability comparison between HCPE-phalloidin upon continuous 
excitation at 488 nm (circles), 405 nm (squares), and Alexa Fluor ® 488-phalloidin 
upon continuous laser excitation at 488 nm (triangles) for 0 to 10 mins (1 mW for 405 
nm laser and 1.25 mW for 488 nm laser). I0 is the initial fluorescence intensity and I is 
the fluorescence intensity of the corresponding sample after continuous scanning for 
designated time intervals.  
 
6.4 Conclusion 
In conclusion, we demonstrate F-actin cytoskeleton imaging in living Hela cells using 
phalloidin-modified HCPE nanospheres as the fluorescent probe. The probe design 
takes advantage of unique hyperbranched core-shell molecular structure that facilitates 
cellular uptake and the phalloidin molecules that specifically bind to F-actin. 
Visualization of F-actin is realized through direct incubation of the cells with 
HCPE-phalloidin for 2 h at 37 °C, and the nanospheres are internalized through 
clathrin- and caveolae-independent energy-dependent pathway, which eliminates the 
needs for specific instruments or sophisticated techniques to induce cellular 
internalization. As the size and fluorescent properties of HCPEs could be fine-tuned 
through conjugated core design and the targeting ability of HCPEs can also be 
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desirably modified through conjugation with diverse biorecognition moieties, this 
study provides a novel molecular design concept for CPEs to meet the needs for 
complicated biological imaging and detection. The first demonstration of CPEs for 
intracellular target detection will inspire great enthusiasm in the development of novel 
CPE-based probes for subcellular protein imaging and tracking in living cells. 
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Conjugated polymer based nanoparticles have recently received increasing attention in 
bioimaging applications because of their tunable optical properties, high fluorescence, 
good photostability and low cytotoxicity. As compared to the well-established 
methodologies of conventional fluorescent probes (such as organic dyes and QDs) in 
cell imaging studies, the exploration of CP NPs as promising alternatives to 
conventional ones is still at its early stage. The main theme of this thesis is to develop 
conjugated polymer based fluorescent nanoparticles for targeted cancer cell detection 
and intracellular biotarget detection with good sensitivity and selectivity, which are of 
high importance in early cancer diagnosis and cytoplasmic process studies. The 
significant findings obtained in each step are outlined in the following content. 
Firstly, we developed a general strategy to fabricate CP NPs using PLGA as an 
encapsulation matrix through a solvent extraction/evaporation single emulsion method, 
which yielded nanoparticles with the emission color from blue to red. After incubation 
with MCF-7 breast cancer cells, bright fluorescence from corresponding CP NPs 
internalized into cytoplasm were clearly observed. PLGA as the encapsulation matrix 
allowed for further conjugation with targeting ligands for specific recognition of 
biosubstrates. After surface functionalization with folic acid, the internalization of 
nanoparticles by MCF-7 cancer cells showed significant enhancement via folate 
receptor-mediated endocytosis, due to the overexpression of folate receptors in the cell 
membranes. Further studies indicated that the as-prepared CP NPs possess good 
photostability and low cytotoxicity. 
We further synthesized CP NPs with surface antibody functionalization and improved 
quantum yield to achieve targeted cancer cell discrimination in both suspension and 
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substrate. Incorporation of POSS as a rigid core into conjugated polymer chains could 
effectively prevent the fluorescent arms from close packing to form low-energy and 
nonfluorescent aggregates upon nanoparticle formulation, leading to higher quantum 
yield of CP NPs. The surface amino groups of CP NPs were well-controlled using a 
mixture of PLGA-b-PEG-NH2 and PLGA-OCH3 as encapsulation matrix. After 
functionalization with trastuzumab that was able to specifically bind to HER2, the 
internalization of nanoparticles into HER2-positive cancer cells (SKBR-3 breast 
cancer cells) was efficiently enhanced. The influence of surface trastuzumab density on 
SKBR-3 cancer cell uptake was studied and the optimized nanoparticles were used to 
discriminate SKBR-3 cancer cells from MCF-7 cancer cells and NIH/3T3 fibroblast 
cells with low expression level of HER2. 
Based on the studies on single type of target cancer cell detection, we further designed 
two PFV based fluorescent nanoparticles with surface anti-HER2 affibody and RGD 
peptide functionalization to facilitate simultaneous discrimination of HER2 positive 
and integrin receptor positive cancer cells in mixture under single laser excitation. 
PFVBT with energy donor-acceptor structure was synthesized by incorporating a 
certain percentage of BT units as the low-energy trap into PFV backbone. Upon 
nanoparticle synthesis, PFVBTNPs showed similar absorption maximum but 
dramatically red-shifted emission maximum as compared to PFVNPs. Due to the 
specific surface functionalization and minimal fluorescence interference between 
PFVNPs and PFVBTNPs, simultaneous detection of SKBR-3 breast cancer cells and 
HT-29 colon cancer cells in one mixture was realized with good selectivity and 
sensitivity. 
In addition to targeted cancer cell detection, intracellular protein labeling in living cells 
was also carried out using conjugated polymer based probes. HCPE nanospheres born 
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with fluorescent properties and three-dimensionality were synthesized and conjugated 
with phalloidin. After incubation with Hela cells for 2 h at 37 °C, the nanospheres were 
internalized through a clathrin- and caveolae-independent energy-dependent pathway 
to facilitate direct F-actin imaging. This is the first report to use conjugated polymer 
based fluorescent probes for intracellular target detection. Moreover, this strategy is of 
high importance in intracellular target imaging as it does not require specific 
instruments or sophisticated techniques to deliver the probes into living cell cytoplasm. 
In this thesis, the design and application of conjugated polymer based fluorescent 
probes for specific targeted cacer cells and intracellular protein detection have been 
successfully demonstrated. The thesis clearly demonstrates a general strategy to 
fabricate conjugated polymer based fluorescent nanoprobes for versatile bioimaging 
studies, which supplies a gap in the application of functionalized conjugated polymer 
nanoparticles. These conjugated polymer based probes have shown tunable fluorescent 
signature, good photostability and low cytotoxicity, making them a promising 
alternative to conventional fluorescent probes such as organic dyes and QDs. From the 
viewpoint of material science and bioconjugation chemistry, customized conjugated 
polymer based fluorescent probes with desired optical property, targeting ability and 
dimensionality would make significant contributions to the current research field of 
fluorescence imaging. Thus, this project provides new opportunities and guidelines for 
future development of conjugated polymer based fluorescent probes in bioimaging 
applications. 
7.2 Recommendation 
We have successfully demonstrated the fabrication and application of conjugated 
polymer based nanoparticles in cell imaging studies. This novel class of fluorescent 
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nanomaterials is worth of further investigation to boost the development of 
high-performance fluorescent probes for in vitro and in vivo imaging.  
First of all, multifunctional nanoparticles integrated with different modalities can be 
explored by taking advantage of the unique merits of nanoparticles. As compared to 
nanoparticles with single modality, multifunctional nanoparticles offer great potential 
to satisfy the increasing requirements in advanced biotechnology. Due to the urgent 
demand of advanced imaging probes in biological researches, multifunctional 
nanoparticles that combine tumor targeting ability with fluorescent and magnetic 
properties have attracted great interest. These multifunctional probes can benefit in 
vivo cancer diagnosis and surgical guidance through detection in both modes. In 
addition, to achieve low autofluorescence and deep tissue penetration for in vivo 
fluorescence imaging, multifunctional fluorescent-magnetic nanoparticles with 
emission in far-red/near-infrared (FR/NIR) region (650-1000 nm) are highly desirable 
to facilitate in vivo dual-modal imaging research. Upon incorporation of iron oxides 
and conjugated polymers with energy donor-acceptor backbones, multifunctional 
nanoparticles with superparamagnetic properties as well as emission wavelength 
within FR/NIR region can be yielded. 
Multifunctional nanoparticles that are integrated with diagnosis and therapeutic 
properties have been widely used in biomedical applications, which provide 
opportunities for noninvasive and real-time monitoring of drug delivery and release 
profile in tumors. This simultaneous imaging and therapeutic ability holds great 
promises in practice over conventional chemotherapy. Considering conjugated 
polymers have shown unique signal amplification by the collective response, the 
dissociation between drug molecules and conjugated polymers will result in 
fluorescence recovery. The real-time fluorescence response of conjugated polymers 
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will be useful for monitoring drug release profile in in vitro and in vivo studies. The 
good biocompatibility, high fluorescence and good photostability of conjugated 
polymers can also benefit long term real-time investigation in vivo. 
Two-photon absorbing (TPA) materials that can be excited in the NIR region have 
attracted intensive attentions in bioimaging studies. Moreover, two-photon 
fluorescence techniques have also been actively investigated for photodynamic therapy. 
The significant advantages of TPA imaging over conventional single-photon 
fluorescence imaging techniques include a highly confined excitation, intrinsic 
three-dimensional resolution and the increased penetration depth in tissue with reduced 
photodamage and background fluorescence. The great limitation of TPA imaging in 
current researches is the lack of water-soluble TPA probes with large TPA cross 
section. Conjugated polymers with electron-donating and accepting groups in 
backbone structure have great potential to possess large TPA cross section. Through 
customized material design, conjugated polymer based nanoparticles are believed to 
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